EquityZen
EquityZen is not a pre-IPO trading platform; it's a packaged private equity product with retail access. Morgan Stanley-owned, 2.5% transaction fees (post-2026), $5K-$50K minimums, K-1 tax reporting, multi-year illiquidity. AltStreet has enumerated the platform's complete funded-SPV census from SEC Form D: 1,967 SPVs, $1.592B, 2015-2026, as of October 23, 2026.
No platform response on record for this review. Is this your platform? Respond or claim it.
What the data actually shows - TL;DR
EquityZen is not a pre-IPO trading platform — it's a packaged private equity product with retail access, now owned by Morgan Stanley. The fee cut to 2.5% post-acquisition makes it the lowest-cost entry point in the pre-IPO secondary market.
In most Standard and Express offerings you buy SPV membership interests, not the company's shares directly (Direct acquisitions are the exception). IPO does not mean liquidity — sale may be delayed until the later of the post-IPO lockup expiry or one year from the fund's purchase date.
Buyer fee post-Morgan Stanley acquisition (February 2026), down from the prior 5% tiered structure — now the lowest among major pre-IPO platforms. Sellers pay a separate 2.5%, so EquityZen collects roughly 5% of platform-level friction per completed transaction. The buyer directly bears 2.5%; the seller-side fee may be reflected in asking prices but is not an additional charge against the buyer.
Platform-stated net aggregate return across realized investments. It excludes the unresolved portion of the portfolio, and EquityZen does not disclose the return distribution, vintage composition, hold periods, capital weighting, or how write-offs are treated. Whether failed positions are excluded is not established — a written-down company could still count as a realized exit.
Advertised entry minimum post-acquisition (February 2026). Minimums vary materially by deal and by deal type. AltStreet observed Standard listings at a $10,000 minimum on 13 July 2026, while older platform materials cite $50,000 as the standard single-company minimum.
Direct listings observed the same day ranged from roughly $152,000 to $300,000, against platform materials citing $200,000+. Express listings carry irregular, to-the-cent minimums because each represents an entire existing SPV position being resold. Treat any single published minimum as indicative.
EquityZen's complete funded-SPV census, enumerated from SEC EDGAR Form D filings — $1.578B raised across 49,950 subscription positions, 2015-2026 (census as of September 16, 2026). Fund I is the retail engine (1,859 SPVs, $1.354B, $29,197 average subscription). Fund II is a separate institutional product (28 SPVs, $116.2M, $123,858 average). They are not the same experience and they are moving in opposite directions.
Share of EquityZen's sequentially numbered Fund I series that were allocated but have no corresponding Form D. AltStreet observes the absence of a filing; it does not observe whether every allocated number represented a staged, investor-facing deal. The rate ran near 2% in 2018-2021, hit 68% for series staged between June 2022 and March 2023, and recovered to roughly 9% by 2024-2026. AltStreet observes that a series was numbered and no filing followed; it does not observe why.
Form D data sourced from SEC EDGAR via quarterly master index enumeration (2014-2026 filings; funded vintages 2015-2026), not sampling. Coverage spans Growth Technology Fund LLC, Growth Technology Fund II LLC, Growth Access Fund LLC (first filing July 2026), Growth Opportunity Funds II-XI, Thematic Fund LLC, and the pre-2016 per-company legacy vehicles. Investor figures throughout are subscription counts, not unique investors — Form D does not permit de-duplication across SPVs.
Quick Verdict
Is this platform right for you?
EquityZen is the most retail-packaged pre-IPO secondary platform — lowest fees post-2026 (2.5%), ROFR handled at the platform level, and the simplest SPV structure in the market. The Morgan Stanley acquisition adds institutional credibility and distribution reach.
Read the full assessmentShow less
The tradeoffs are real: illiquidity measured in years, K-1 complexity, and a 74% aggregate return that cannot be annualized, weighted, or verified. Best for first-exposure pre-IPO investors who want simplicity over price discovery.
Best for
- First-time pre-IPO investors who want simplicity and platform-administered ROFR handling
- High-income accredited investors with 3-7 year time horizons and K-1 tolerance
- Investors who want diversified exposure via Opportunity Funds or themed baskets
- Investors prioritizing fee efficiency over maximum price transparency
Avoid if
- You need liquidity within 3 years
- You expect to trade in and out of positions — this is buy-and-hold only
- You are investing primarily to chase one marquee name like SpaceX or OpenAI
- You cannot absorb multi-year K-1 complexity or potential tax extension requirements
Top strengths
- Lowest transaction fees in the pre-IPO secondary market post-2026 (2.5%)
- ROFR administered at the platform level — EquityZen manages the process, though the buyer remains exposed to the deal being blocked or terminated
- Morgan Stanley ownership adds institutional credibility and $5K entry minimum
- Fund II institutional product ($208,039 average subscription) for larger allocations
- Deepest SPV issuance record in the category — 1,933 funded vehicles and $1.565B since 2014, versus 104 vehicles for Hiive
- Opportunity Funds provide diversification across multiple names (the Thematic Fund appears inactive, with no new Form D since May 2024)
Key limitations
- Indicative pricing only — a Reference Price and aggregate bid/ask volume are shown, but there is no executable order book, and EquityZen states this market data is proprietary and confidential
- EquityZen reports serving 450+ companies historically, while Hiive advertises a substantially larger company catalog — the figures are differently defined and are not a direct inventory comparison
- K-1 reporting with timing that varies by vehicle type and may require extensions
- 74% aggregate return covers realized investments only; hold periods, weighting and write-off treatment are undisclosed, so it cannot be annualized or independently verified
- SPV structure means you own membership interests, not direct equity
- Portfolio company is never named in the Form D — platform-level concentration cannot be verified from primary sources by anyone
- Retail subscription size has fallen 44% since 2015 ($28,143 to $15,651 median) while the institutional product moved the other way
Quick Answers
What most investors want to know first
The highest-signal facts first: minimums, liquidity reality, K-1 timing, and whether distributions are actually part of the experience.
Minimum
Platform-stated minimums post-Morgan Stanley acquisition: $5,000 industry-lowest minimum (per February 2026 announcement); $10,000 for enhanced access members (requires maintaining $50,000 balance for reduced minimums, early access to high-demand deals, and waitlist prioritization); $20,000 limited slots for multi-company funds. AltStreet observed live deal listings on 13 July 2026 showing Standard offerings at a $10,000 minimum — materially below the $50,000 figure cited in older platform materials for single-company funds — and Direct offerings ranging from roughly $152,000 to $300,000 rather than a flat $200,000 floor. Express listings carry irregular, to-the-cent minimums because they represent an entire existing SPV position being resold, not a subscription tranche. Minimums vary substantially by deal and by deal type; treat any single published figure as indicative.
Liquidity
Secondary liquidity exists only in a conditional sense. Express Deals are real, but they are not broadly available to every investor or every position. Eligibility commonly requires more than 2% ownership of the original fund, satisfaction of minimum holding periods, and a single buyer for the full position. Investors entering at $10K-$20K minimums should generally assume Express Deal liquidity will not be available to them.
K-1 Timing
K-1 timing depends on structure. Standard single-company funds usually issue a K-1 only when a taxable event occurred, and when issued those documents generally target early March. Diversified managed funds usually issue annual K-1s from inception through liquidation, with a more realistic target of late March to early April. Dual-layer funds that depend on upstream third-party fund reporting can push K-1 delivery into August or September.
Distributions
Investor economics are primarily back-end loaded. Standard single-company funds should be treated as zero-yield until an IPO, acquisition, liquidation, or eligible secondary sale occurs. Multi-company managed funds can distribute cash as underlying portfolio exits occur, but those distributions are staggered and event-driven rather than periodic income payments.
Overview
Platform Overview
A concise read on what the platform is, how the structure works, and where the practical friction shows up for real investors.
Secondary marketplace platform facilitating pre-IPO share transactions between existing shareholders (employees, early investors) seeking liquidity and accredited investors seeking exposure to late-stage private companies. EquityZen operates as a registered broker-dealer (SEC-registered; FINRA CRD 281820; SIPC coverage) and structures most investments through special purpose vehicle (SPV) LLCs where investors buy membership interests rather than direct shares. Now a wholly-owned subsidiary of Morgan Stanley Wealth Management following January 2026 acquisition.
Core offerings include standard single-company funds, diversified managed funds, Express Deals, and larger direct share acquisitions. Investors pay 2.5% upfront fees (reduced from 5% in February 2026), usually hold positions for multiple years, and should underwrite deals as illiquid private placements where tax timing, post-IPO lockups, and actual secondary resale availability depend heavily on structure.
The deal brought EquityZen's marketplace and technology into Morgan Stanley's broader private markets ecosystem, and immediately coincided with a fee cut from 5% to 2.5% on both buyer and seller sides (effective February 19, 2026), making EquityZen the lowest-fee major pre-IPO platform. The marketplace facilitates transactions where existing shareholders sell equity to new investors through SEC Reg D structures, with EquityZen operating as broker-dealer and most deals wrapped in SPV LLCs managed on behalf of investors. Per refreshed platform materials as of April 2026, EquityZen reports 850K+ subscribers, 450+ companies served, $1.5B+ distributed to selling shareholders, $710M+ distributed to investors, and 53K+ company-approved transactions.
Featured companies span AI, fintech, biotech, defense tech, and consumer categories, but inventory depends on actual seller supply and company approval. Investment structure matters more than the headline marketplace pitch: standard single-company funds are generally zero-yield until exit, diversified managed funds can distribute cash only as portfolio exits occur, and dual-layer structures can materially delay tax reporting because upstream fund K-1s must arrive first. EquityZen advertises entry minimums as low as $5,000, but minimums vary materially by deal and by deal type.
AltStreet observed Standard listings at a $10,000 minimum on 13 July 2026, while older platform materials cite $50,000 as the standard single-company minimum. Direct listings observed the same day ranged from roughly $152,000 to $300,000, against platform materials citing $200,000+. Express listings carry irregular, to-the-cent minimums because each represents an entire existing SPV position being resold.
Treat any single published minimum as indicative. Investor fees are now 2.5% up to $1M and 2.0% above $1M — sellers pay 2.5% — and platform-reported 74% net aggregate returns should be read cautiously because they cover realized investments only, exclude the unresolved portion of the portfolio, and disclose no hold periods, capital weighting, return distribution, or treatment of write-offs. The platform is best understood as a structured but still illiquid private-placement marketplace: useful for accredited investors seeking pre-IPO exposure, but unsuitable for anyone who needs dependable liquidity, recurring income, or simple tax reporting.
Founded & Structure
2013 by Shriram Bhashyam, Atish Davda (CEO), Phil Haslett (CSO); acquired by Morgan Stanley Wealth Management in January 2026 (closed); operates through EquityZen Securities LLC broker-dealer subsidiary (FINRA CRD 281820); headquarters New York City; 850K+ subscribers per refreshed April 2026 platform materials. Morgan Stanley expects ~$100M in integration costs over two years.
Platform Scale
Per refreshed platform materials as of April 2026: 850K+ subscribers, 450+ companies served, 53K+ company-approved transactions, $1.5B+ distributed to selling shareholders, and $710M+ distributed to investors since founding in 2013.
Company Focus
Late-stage private companies with established business models, significant VC backing, typical valuations $500M-$10B+, perceived proximity to liquidity events; focus on tech unicorns (AI, fintech, SaaS, defense tech, biotech); examples of companies that have appeared on platform or similar secondary marketplaces include SpaceX, OpenAI, Anthropic, Stripe, Databricks, Anduril Industries, xAI, Perplexity, Groq, Figure AI—specific inventory varies and availability depends on shareholder supply.
Access to Flagship Names
You can sometimes buy exposure to companies like SpaceX or OpenAI on EquityZen, but availability is inconsistent and highly supply-driven. The platform can market marquee names, yet actual access depends on whether existing shareholders are selling, whether the company approves transfers, whether allocations survive waitlists, and whether minimums fit your account size.
Investment Structures
Three primary offerings: (1) standard single-company funds through SPV LLCs, (2) multi-company diversified or thematic managed funds, and (3) direct share acquisitions for larger investors; Express Deals function as a conditional secondary resale path rather than a universally available liquidity feature.
Investment Minimums
Platform-stated minimums post-Morgan Stanley acquisition: $5,000 industry-lowest minimum (per February 2026 announcement); $10,000 for enhanced access members (requires maintaining $50,000 balance for reduced minimums, early access to high-demand deals, and waitlist prioritization); $20,000 limited slots for multi-company funds. AltStreet observed live deal listings on 13 July 2026 showing Standard offerings at a $10,000 minimum — materially below the $50,000 figure cited in older platform materials for single-company funds — and Direct offerings ranging from roughly $152,000 to $300,000 rather than a flat $200,000 floor. Express listings carry irregular, to-the-cent minimums because they represent an entire existing SPV position being resold, not a subscription tranche. Minimums vary substantially by deal and by deal type; treat any single published figure as indicative.
Fee Structure
Post-Morgan Stanley acquisition (effective February 19, 2026): Investors pay 2.5% on investments up to $1M, 2.0% above $1M (example: $50,000 investment requires $51,250 wire transfer). Sellers pay 2.5% at close, with reduced rates for larger blocks. Fees cut in half from prior structure (5% up to $500K, 4% for $500K-$1M, 3% for $1M+). Platform does not charge carried interest or ongoing management fees on single-company SPVs; multi-company funds may have additional administrative or management costs — review specific offering documents for complete fee disclosure. For Direct Share Acquisitions the threshold is different: 2.5% up to $10M, 2.0% above $10M (per Morgan Stanley press release February 2026 and EquityZen Help Center). Termination fee: $500 if investor fails to complete investment within specified timeframe per deal terms.
Accreditation Requirements
SEC-defined accredited investor status required: Individual—$200K+ annual income ($300K+ joint with spouse) in each of prior two years with reasonable expectation of same for current year, OR $1M+ net worth (excluding primary residence). Entity—various qualifications including $5M+ assets or qualifying family office. Verification methods vary by offering structure—investors complete questionnaires and provide binding representations; certain offerings (particularly 506(c)) may require additional documentation for reasonable verification steps per SEC requirements.
Investment Process
1) Sign up and verify accredited status, 2) Browse live offerings or indicate interest in preview offerings (reserve allocation or join waitlist), 3) Review offering documents and company information, 4) Execute legal documents and provide payment via ACH/wire, 5) Deal closing timelines and company approval processes vary by specific offering—review deal terms for ROFR periods and expected transaction completion timeframes, 6) Upon approval, investors receive SPV membership interest, 7) Active portfolio management with personalized updates until exit.
Hold Periods & Exits
Typical underwriting assumption is 2-5+ years of illiquidity, but actual liquidity can take longer. Exit mechanisms: (1) IPO, after which shares may still be locked until the later of a standard post-IPO lockup expiry or one year from the fund purchase date, (2) acquisition or merger, where proceeds are distributed per deal terms, and (3) eligible Express Deal resale, which should be treated as opportunistic rather than dependable.
Should You Use EquityZen?
Use it if
you want late-stage private-company exposure at the lowest fees in the secondary market (2.5% post-2026), can hold for years, can diversify across multiple positions or funds, and are comfortable with SPV structure, K-1 complexity, and delayed liquidity. Morgan Stanley backing adds institutional credibility and distribution reach.
Avoid it if
you need liquidity, are joining mainly to chase one specific marquee name like SpaceX or OpenAI, or expect early-stage venture-style upside from already-expensive late-stage companies.
Reality Scorecard
Access to top companies: limited and inconsistent. Liquidity: very low. Fees: high enough to create real performance drag. Transparency: low relative to public equities. Upside potential: real, but moderated by late-stage entry pricing and long hold periods.
Historical Performance
Platform reports 74% net aggregate return across realized investments (per company materials)—'net' is said to reflect deduction of transaction fees, though the platform does not define precisely what net includes. Third-party sources cite a historical range from total loss to 450%+ gains, with highly variable outcomes by deal and vintage. Past performance is not indicative of future results. The figure carries realization bias: it covers the realized portion of the portfolio and excludes the unresolved portion. Whether written-down or liquidated positions are counted as realized exits is not disclosed. EquityZen publishes no return distribution, no vintage composition, no hold periods and no capital weighting, so the figure cannot be annualized, weighted, or independently verified.
SPV Structure
Most investments use special purpose vehicle (SPV) LLCs managed by EquityZen or an affiliate. Investors receive membership interests in the entity that owns the underlying shares rather than direct stock ownership. This structure enables smaller check sizes and centralized administration, but it also creates K-1 tax reporting, fund-level governance, and another layer between the investor and the company.
Company Approval Process
After investor commitments received, companies exercise right of first refusal (ROFR) typically 30 days to purchase shares on same terms as investor offer; companies can block secondary transactions, impose transfer restrictions, or negotiate modified terms; deal may terminate if company exercises ROFR or declines approval, creating uncertainty even after investor commitment.
Tax Treatment
SPV membership interests are generally taxed as partnership interests. Investors may receive Schedule K-1 reporting for income, gains, losses, and deductions, with timing varying by vehicle type: standard single-company funds often only issue a K-1 when a taxable event occurs, diversified funds generally issue annual K-1s, and dual-layer structures can be delayed into late summer. Complex tax reporting makes the platform materially less convenient than public-market brokerage investing.
Competitive Positioning
Three platforms, three different problems solved. EquityZen: curated, retail-packaged, lowest fees post-2026 (2.5%), SPV structure means EquityZen administers ROFR rather than the individual buyer — best for first-time pre-IPO investors or those prioritizing simplicity and fee efficiency. Forge Global: institutional infrastructure — marketplace, price data (Forge Price on Yahoo Finance), fund management, and integrated IRA custody via Forge Trust Co.; best for investors who need the full private markets stack and can engage with specialist advisors. Hiive: best live price discovery via real-time order book with actual, executable bids and asks — EquityZen now publishes a Reference Price and aggregate bid/ask volume per company, but it is indicative rather than executable and the platform designates it confidential; 0% management fee / 0% carry on Hiive Funds makes it the most capital-efficient structure for long holds; advertises a substantially larger company catalog, though EquityZen's 450+ figure counts companies served historically and the two are not defined the same way. The wrong choice is the platform that sounds most credible on its homepage — the right choice is the one whose structure matches what you actually need the platform to do.
Information Access
Limited company information disclosure—investors receive offering documents with basic company description, valuation, recent financing history, and risk factors; no access to detailed financial statements, board materials, or ongoing operational metrics unlike public company SEC filings; information asymmetry heavily favors company insiders and early investors; must conduct research with limited data.
Visual Summary
Outcome Scenarios
A simple way to underwrite the range of realistic outcomes before you anchor on marquee company names or headline return statistics.
Best case
IPO or acquisition at a meaningfully higher valuation after a long hold, with returns strong enough to clear fees and illiquidity drag.
Base case
Modest positive return after years of waiting, fee friction, lockups, and limited interim information.
Worst case
No usable liquidity, down-round pricing, indefinite hold, or a total loss if the company fails or exits poorly.
ASThe EquityZen Illusion vs Reality
- The platform feels like: a marketplace, a trading venue, access to hot startups. It behaves like: a private equity fund with illiquidity, delayed K-1 reporting, limited exit control, and binary outcomes. The interface is consumer-grade. The investment structure is institutional-grade complexity.
- 74% aggregate return is a number with its inputs missing. It cannot be annualized, because EquityZen discloses no hold periods — 74% over three years and over ten years are entirely different investments. It cannot be adjusted for fees, because the platform calls it net without defining what net includes. It cannot be capital-weighted, because allocation across deals is undisclosed. And it covers realized investments only, so the unresolved portfolio is invisible. Four missing inputs, every one of which only EquityZen can supply.
- Secondary pricing creates adverse selection risk. Shareholders selling pre-IPO may possess private information about company challenges, slowing growth, or delayed exit timing not available to buyers. Professional venture capitalists buy in primary rounds with information rights and board seats. Secondary investors buy with a company description and a valuation based on the last round — which may be 18 months old.
- Platform-level friction of roughly 5% per transaction (2.5% buyer + 2.5% seller, post-February 2026) is down from the prior 8-10% structure. The buyer directly bears 2.5% and must clear that plus the opportunity cost of multi-year lockup. Traditional venture-fund economics are structured differently and may be more or less expensive depending on performance, duration and how the fee base is calculated.
- Late-stage entry points limit upside. Companies valued at $10B-$200B+ have already captured substantial appreciation from seed/Series A valuations. Paying $100B+ for SpaceX or $157B for OpenAI requires belief in multi-hundred-billion or trillion-dollar outcomes just to generate venture-style returns.
Key Gaps & Non-Disclosures
- Distribution of returns behind the 74% aggregate — median, quartiles, loss rate, vintage composition, hold periods, capital weighting, and write-off treatment. The aggregate could reflect 20% of deals generating 300%+ while 80% lost money. This data does not exist publicly.
- ROFR exercise rates and deal failure rates — what percentage of transactions fail after investor commitment due to company blocking. This directly affects deployment risk for committed capital and is not disclosed.
- Current mark-to-market on ongoing holdings — investors in non-exited positions have no visibility into how private valuations moved since entry. Particularly significant for 2021 vintage investors who entered at peak valuations.
- Whether EquityZen entry pricing is at a premium or discount to the most recent institutional financing round — 'based on recent rounds' language does not tell buyers whether they are paying par, a premium, or negotiating against stale data. AltStreet observed live listings priced above the platform's own Reference Price while displaying a headline discount to the last venture round.
- Why concurrent listings for the identical security carry materially different prices, and whether any best-execution duty applies. AltStreet observed an eleven-listing spread of 42% on a single security on a single day, with no dispersion warning surfaced to the buyer.
- Time-to-exit by vintage cohort — actual holding periods from investment to liquidity event would reveal whether the '2-5 year' guidance is realistic. Many 2018-2021 vintage investments remained illiquid through 2024 as IPO markets closed.
- Company-level concentration across the platform's $1.565B — structurally unavailable from primary sources, because Fund I Form D filings identify the vehicle by series number and never name the portfolio company. EquityZen named companies in its filings until roughly 2016 and then stopped. This gap cannot be closed by any external analyst.
- Deal-staging attrition — EquityZen numbers Fund I series sequentially and does not disclose how many numbered series never close. AltStreet has measured the gap directly from the filing record: 20.5% of matured series never produced a Form D, rising to 68% for series staged between June 2022 and March 2023. The platform offers no figure of its own, and the filings do not establish cause.
Investor Operations
The practical questions investors actually care about: when tax documents arrive, how cash distributions work, and whether capital can be exited before the underlying asset is sold.
Tax Documents
K-1 Timing
What to expect
K-1 timing depends on structure. Standard single-company funds usually issue a K-1 only when a taxable event occurred, and when issued those documents generally target early March. Diversified managed funds usually issue annual K-1s from inception through liquidation, with a more realistic target of late March to early April. Dual-layer funds that depend on upstream third-party fund reporting can push K-1 delivery into August or September.
Delay signals
- Dual-layer or multi-layer structures create the highest delay risk because EquityZen cannot finalize investor K-1s until it receives upstream fund reporting.
- Diversified managed funds can still arrive close enough to April 15 that many investors and CPAs will default to filing an extension.
- If you prefer to file taxes early, verify the exact fund structure before investing rather than assuming all EquityZen deals behave like a standard single-company SPV.
Extension risk
For dual-layer vehicles, an extension is functionally the default because target delivery falls after April 15. For diversified managed funds, an extension is not always mandatory but is often the practical operating assumption. Standard single-company funds may avoid the issue in years with no taxable event.
Confidence: High
Cash Flow
Distributions
Timing
Investor economics are primarily back-end loaded. Standard single-company funds should be treated as zero-yield until an IPO, acquisition, liquidation, or eligible secondary sale occurs. Multi-company managed funds can distribute cash as underlying portfolio exits occur, but those distributions are staggered and event-driven rather than periodic income payments.
Consistency
No reliable recurring distribution schedule exists at the platform level. These are not dividend instruments; any cash flow is contingent on realized exits, not on a quarterly or annual income policy.
Confidence: High
Liquidity
Exit Reality
Holding period
Liquidity is limited both before and after an exit. EquityZen investments are private placements subject to holding-period requirements. After an IPO, a standard 180-day lockup often applies, and restricted-security rules can extend actual liquidity until the later of the lockup expiry or one year from the fund's purchase date.
Exit options
- Primary exit path is a company liquidity event such as an IPO, merger, or acquisition, after which investors receive shares and/or cash.
- A secondary exit may be possible through an eligible Express Deal, where an investor sells an allocation to another investor on EquityZen's marketplace.
- Share transfers remain subject to company approval, offering-specific restrictions, and actual buyer demand.
Secondary market
Secondary liquidity exists only in a conditional sense. Express Deals are real, but they are not broadly available to every investor or every position. Eligibility commonly requires more than 2% ownership of the original fund, satisfaction of minimum holding periods, and a single buyer for the full position. Investors entering at $10K-$20K minimums should generally assume Express Deal liquidity will not be available to them.
Confidence: High
Investment Structures
Single-Company Funds (Standard & Express Deals)
Concentrated exposure to one pre-IPO company through an SPV LLC where multiple investors pool capital to purchase shares from selling shareholder(s). Standard deals involve the full diligence and documentation process with company approval via ROFR. Express Deals are secondary resales within the platform, but eligibility is narrower than the marketing label implies.
Investors receive membership interests in the SPV rather than direct company shares. Minimums vary materially by deal. AltStreet observed Standard listings at a $10,000 minimum on 13 July 2026; older platform materials cite $50,000 as the standard single-company minimum.
Fees are 2.5% upfront (post-February 2026) plus 2.5% seller-side transaction costs. Exit usually depends on IPO, acquisition, or another company liquidity event. If the company goes public, investors may still wait until the later of a standard IPO lockup expiry or one year from fund purchase before shares become saleable. Risk remains concentrated, illiquid, and binary.
Multi-Company Funds (Growth Opportunity & Thematic)
Diversified exposure across multiple pre-IPO companies in a single fund, reducing single-company concentration risk while preserving late-stage private-market exposure. Growth Opportunity and thematic funds are curated portfolios built by the platform rather than investor-customized baskets. Investors generally receive annual K-1s from inception through liquidation, typically later than standard single-company funds because multiple portfolio positions must be aggregated.
Exit timing is staggered as individual holdings are sold, acquired, or distributed, so cash flow is irregular and event-driven rather than periodic income. These funds improve diversification but can increase tax-reporting complexity and still leave investors with long-duration illiquidity.
Direct Share Acquisitions
Direct ownership of company shares for larger investors ($200,000+ typical minimums) seeking position on company capitalization table with potential information rights and communications. Structure: Investor purchases shares directly via EquityZen-brokered transaction rather than through SPV pooling mechanism; direct name on company cap table; potentially negotiated information rights or communication privileges depending on company policies and investment size. Benefits: Direct ownership eliminates SPV management layer and K-1 complexity; shares held in investor name not pooled vehicle; potential for enhanced information access and company communications; greater flexibility for estate planning and transfer.
Tradeoffs: Higher minimums ($200K-$500K+ typical) limiting accessibility; still subject to company ROFR approval and transfer restrictions; limited liquidity until company liquidity event; may require more extensive legal documentation and negotiation. Fees: for Direct Share Acquisitions specifically, 2.5% up to $10M and 2.0% above $10M (post-February 2026) — a different threshold from the $1M breakpoint that applies to Standard and Express offerings. Seller fee 2.5%, negotiable for larger blocks.
Exit: Shares transfer to investor brokerage account upon IPO after lockup period; cash or acquirer shares upon acquisition; potential secondary marketplace sales subject to company approval and finding buyers. Suitable for: High-net-worth investors or family offices making substantial private equity allocations, those seeking simplified ownership structure versus SPV interests, and investors desiring potential information rights and cap table presence. Not suitable for: Retail investors unable to deploy $200K+ per position or those seeking diversification through lower minimums.
Risk
Risk Structure
This is where the marketplace pitch gives way to the actual operating reality: delayed exits, limited disclosure, fee drag, and path-dependent outcomes.
Illiquidity and undefined hold periods
Investments are illiquid with typical 2-5 year expected hold periods, but actual timing depends entirely on company decisions regarding IPO/acquisition outside investor control—some companies remain private 7-10+ years; secondary marketplace sales possible but depend on buyer demand and company approval with no guarantees.
Binary outcomes and total loss potential
Single-company funds create concentrated exposure with binary risk—companies either achieve successful exits (IPO, acquisition) generating returns or fail entirely resulting in 100% capital loss; historical range from total losses to 450%+ gains with highly skewed distribution where few winners drive aggregate returns.
Valuation opacity and pricing risk
Private company valuations lack public market transparency and based on recent financing rounds that may be stale, optimistic, or manipulated; secondary pricing determined through seller negotiations not market clearing; disconnect between entry price and fundamental value difficult to assess without detailed financial disclosure.
Company approval uncertainty via ROFR
After investors commit capital, companies exercise right of first refusal (ROFR) with period to purchase shares on same terms or block transaction entirely; creates deal uncertainty where committed capital may not deploy; investors may face fees or allocation reallocation if unable to complete within specified timeframes per deal-specific terms.
Information asymmetry and limited disclosure
Unlike public companies with SEC-mandated quarterly/annual filings, investors receive only offering documents with basic company information and limited updates; no access to detailed financials, operational metrics, or board materials; selling shareholders may possess material non-public information about challenges motivating sales.
Fee drag and performance hurdle
The buyer directly bears a 2.5% fee (post-February 2026); the seller separately bears 2.5%, giving roughly 5% of platform-level friction per transaction. Combined with the opportunity cost of multi-year lockup this is a real performance hurdle, though reduced from the prior 8-10% structure. No ongoing management fees on single-company SPVs.
Extended illiquidity and indefinite hold periods
Investments structured as illiquid private placements with 2-5 year expected hold periods, but actual duration depends entirely on company IPO/acquisition timing outside investor control. Many late-stage companies remain private 7-10+ years; IPO markets closed 2022-2024 extending holds for 2018-2021 vintages.
Why it matters
Capital locked up for undefined period with no guaranteed exit mechanism; cannot access funds for emergencies or redeploy to better opportunities; time-value of money erodes returns if hold periods extend beyond expectations; secondary marketplace sales unreliable and dependent on buyer demand plus company approval.
Mitigation / verification
Only invest capital you can afford to lock up 5-10+ years without needing access; diversify across vintage years to create rolling exit opportunities; understand that 'late-stage' proximity to IPO is not guarantee or timeline; monitor company financing activity and market conditions affecting IPO windows; some positions may remain illiquid indefinitely if companies choose to stay private.
Binary outcomes and total capital loss risk
Single-company funds create concentrated exposure with binary risk profile—companies either achieve successful exits generating returns or fail entirely. Historical outcomes range from 100% loss (company bankruptcy, acquisition at unfavorable terms) to 450%+ gains (successful IPO at premium valuations). Distribution highly skewed where minority of winners drive aggregate returns.
Why it matters
Concentrated bet on single company's success with asymmetric downside—can lose 100% of investment but upside capped by entry valuation and exit timing; unlike diversified mutual funds or ETFs, no portfolio-level protection; venture capital outcomes are highly skewed with many companies failing or underperforming while a few winners drive returns, though late-stage focus reduces early-stage binary risk.
Mitigation / verification
Build a diversified portfolio across multiple single-company investments — which requires substantially more capital than a single advertised minimum; consider multi-company funds for diversification at lower minimums; accept that several positions will likely fail—expect a skewed distribution in which some positions lose money, many produce modest outcomes, and a small number of winners may drive portfolio returns; never invest more than 5-10% net worth in a single position.
Valuation risk and late-stage entry pricing
Private company valuations lack transparent market clearing and based on recent financing rounds that may be stale (6-18 months old), optimistic (inflated during hype cycles), or subject to preferential terms favoring lead investors. Secondary market pricing determined through seller negotiations not competitive bidding. Entry at $10B-$200B+ valuations requires multi-hundred-billion-dollar outcomes for venture-style returns.
Why it matters
May be buying at peak private market valuations; limited upside remaining after early investors captured seed-to-unicorn appreciation; comparable public companies trading at lower multiples suggests private market disconnect; market observations from 2022-2023 downturn showed many late-stage valuations repricing downward significantly while secondary markets remained illiquid.
Mitigation / verification
Conduct independent valuation analysis comparing company metrics to public market comparables; understand what multiple of revenue, EBITDA, or users you're paying relative to sector benchmarks; be skeptical of valuations from recent rounds during frothy markets; consider that late-stage entry captures less upside than seed/Series A but also reduces binary execution risk; review offering documents for preferential terms granted to prior investors (liquidation preferences, anti-dilution, etc.).
Company ROFR and deal termination uncertainty
After investors execute documents and commit capital, companies exercise right of first refusal (ROFR) with period to purchase shares on same terms as investor offer or block transaction entirely. Companies can decline approval, impose additional transfer restrictions, or require modified terms. Deals may terminate even after investor commitment; investors should review deal-specific terms for completion timeframes and potential fees.
Why it matters
Capital may be committed but not deployed, creating opportunity cost and transaction uncertainty; fees may apply if deals fall through or completion deadlines not met per specific offering terms; some companies systematically block secondary transactions to control cap table and limit information leakage; no visibility into company approval likelihood before committing.
Mitigation / verification
Understand that indication of interest and document execution do not guarantee deal consummation; maintain liquidity buffer to fund commitments within one-week completion requirement; research company's history of approving/blocking secondary sales; accept that some committed capital may not deploy; platform provides updates on ROFR status but timeline varies by company responsiveness.
Information asymmetry and limited disclosure
Unlike public companies subject to SEC reporting requirements (10-K, 10-Q, 8-K filings with detailed financials), private companies provide minimal disclosure—offering documents contain basic business description, valuation, recent financing history, and risk factors but no comprehensive financial statements, operational metrics, or ongoing reporting obligations. Selling shareholders likely possess material non-public information about company performance, challenges, or insider outlook.
Why it matters
Investors make decisions with fraction of information available to insiders; adverse selection risk where shareholders selling may know about problems not disclosed to buyers; no visibility into revenue growth rates, profitability trends, burn rate, customer churn, competitive threats, or management changes until after investment made; information gap widens as hold period extends with no ongoing updates.
Mitigation / verification
Conduct external research using public sources: media coverage, Crunchbase/PitchBook data, employee Glassdoor reviews, customer testimonials, competitive analysis; network with industry contacts who may have insider knowledge; understand that limited information access is inherent to private markets and accept higher uncertainty versus public equities; focus on companies with strong brand recognition and external validation reducing information asymmetry.
Fee drag and performance hurdle
Transaction economics post-February 2026: 2.5% buyer fee charged on top of investment amount (for $50,000 investment, investor wires $51,250) plus 2.5% seller fee that may be reflected in pricing. All-in friction approximately 5% of invested amount — reduced from 8-10% prior to Morgan Stanley acquisition but still a meaningful performance hurdle.
Why it matters
Fee drag was reduced by the February 2026 cut but still compounds over multi-year hold periods. The 74% aggregate figure cannot be converted into an annualized return, because EquityZen publishes no hold periods — and because the platform describes the figure as net, subtracting the buyer fee from it again risks double-counting. Traditional venture-fund economics (management fee plus carry) are structured differently and may be more or less expensive depending on performance, hold period, and how the management fee is calculated.
Mitigation / verification
Calculate net return hurdles accounting for upfront fees (2.5% up to $1M, 2.0% above) and opportunity cost of capital; compare post-2026 EquityZen fees against competing platforms (Forge Global, Hiive, others); understand that fees reduce net returns regardless of gross performance; note the February 2026 fee reduction materially improved EquityZen's competitive fee position.
Realization bias and incomplete performance disclosure
Platform's 74% net aggregate return figure carries realization bias: it covers the realized portion of the portfolio and excludes the unresolved portion, which may be underwater at current valuations. Whether written-down or liquidated positions are counted as realized exits is not disclosed, so it cannot be assumed that all failures are excluded. The figure also cannot be annualized — no hold periods are published — and cannot be capital-weighted, because allocation across deals is undisclosed. Distribution of outcomes is likely highly skewed, with few winners driving the aggregate, but EquityZen publishes no distribution.
Why it matters
Marketed returns create inflated expectations of typical experience; actual investor outcomes more variable with many positions generating losses or modest returns while few generate outsized gains; if 20% of deals generate 300%+ returns and 80% lose money, aggregate can still show positive return masking common investor experience; annualized returns could be materially lower than the headline cumulative figure depending on the actual holding periods, which EquityZen does not disclose.
Mitigation / verification
Interpret aggregate return statistics with extreme skepticism—realization bias is inherent to any realized-only figure; ask about distribution of returns (percentage generating positive returns, median outcome, quartile performance) which platform does not disclose; understand venture capital model expects many losses with few winners driving portfolio; set realistic expectations that individual positions highly variable and past aggregate performance not predictive of future specific outcomes.
Sector concentration and correlated risk
Platform's deal flow heavily concentrated in venture-backed technology sector (AI, fintech, SaaS, crypto, defense tech) creating exposure to tech market cycles, interest rate sensitivity, and sector-specific regulatory risks. Featured companies span similar business models (software platforms, marketplace businesses, hardware-software hybrids) with correlated valuations and exit dynamics.
Why it matters
Lack of true diversification even across multiple positions—tech sector downturns (2000 dot-com crash, 2022-2023 contraction) simultaneously impact many holdings; interest rate increases disproportionately hurt high-growth-low-profit tech companies; regulatory changes (antitrust, data privacy, AI regulation) create correlated risks; public tech market multiples directly influence private company exit valuations creating portfolio-wide mark-to-market risk.
Mitigation / verification
Recognize that multiple pre-IPO tech investments do not provide true diversification—all exposed to technology sector performance and exit market conditions; consider balancing with non-tech alternatives (real estate, commodities, other alternative strategies); understand that tech-heavy portfolio amplifies both upside in bull markets and downside in corrections; monitor public tech market multiples as leading indicator of private company exit valuations.
IPO market cyclicality and exit timing risk
Market context: Exit opportunities for pre-IPO investments depend heavily on public market IPO windows which are highly cyclical—strong activity 2020-2021 followed by significant slowdown 2022-2024 following interest rate increases. Companies delay or cancel IPO plans when market conditions unfavorable, extending hold periods beyond initial expectations.
Why it matters
Investments made during strong IPO markets may remain illiquid for extended periods if exit windows close; hold periods can extend 2-4+ years beyond original expectations; some companies abandon IPO plans entirely pursuing acquisitions at less favorable terms or remaining private indefinitely; cannot predict IPO market conditions 3-5+ years forward when making investment decisions today.
Mitigation / verification
Accept that IPO timing outside investor control and subject to macroeconomic conditions (interest rates, inflation, sector rotation, risk appetite); focus on company fundamentals that support acquisition optionality if IPO markets remain closed; understand that 'late-stage' and 'proximity to IPO' marketing language does not constitute timeline guarantee; diversify investment timing across market cycles if building multi-year allocation; monitor IPO market activity as indicator of near-term exit opportunities for existing holdings.
Biggest Misconceptions & What Actually Happens
- Common misconception: 'I am buying SpaceX stock' -> In many EquityZen deals you are buying an SPV membership interest that indirectly holds the shares, not direct common stock in your own name.
- Common misconception: 'IPO means I can sell immediately' -> Even after an IPO, liquidity may still be delayed by a standard lockup plus the later-of-one-year restricted-security timing.
- Common misconception: 'I can flip the position if I change my mind' -> Express Deals exist, but many investors will never qualify for them and should underwrite the position as effectively locked.
- Common misconception: 'Pre-IPO means early' -> EquityZen is generally late-stage exposure after most venture-style multiple expansion has already happened.
- Typical post-investment reality: invest, wait through closing and ROFR, receive limited ongoing updates, hold through an uncertain multi-year period, and if an IPO happens, continue waiting until the position is actually transferable or saleable.
Regulatory & Legal Posture
Security Status
Private placements structured as SEC Regulation D offerings, limited to accredited investors; platform operates as registered broker-dealer (EquityZen Securities LLC, FINRA CRD 281820, SEC registered, SIPC member); wholly-owned subsidiary of Morgan Stanley Wealth Management following January 2026 acquisition
EquityZen offerings are private securities exempt from SEC registration under Regulation D (typically Rule 506(b) or 506(c)), which allows companies to raise capital from accredited investors without public registration requirements. Investments structured as limited partnership or LLC membership interests in SPVs holding underlying company shares. Platform operates through EquityZen Securities LLC, a registered broker-dealer subject to FINRA regulations and SEC oversight, providing regulatory oversight.
SIPC membership may protect qualifying customer cash and securities held by the broker-dealer if the firm fails, subject to statutory limits — it does not protect investment value, issuer failure, or losses in the underlying private investment. SEC Regulation D imposes transfer restrictions on securities—investors must hold for minimum period and cannot freely trade on public markets; secondary sales subject to company approval and platform facilitation. Accreditation strictly enforced per SEC requirements ($200K+ annual income, $300K+ joint, or $1M+ net worth excluding primary residence); verification approach varies by offering structure (506(b) vs 506(c)) and may require additional documentation for reasonable verification steps.
As a registered broker-dealer, EquityZen is subject to conduct standards: recommendations to retail customers are governed by Regulation Best Interest, while FINRA Rule 2111 suitability continues to apply in relevant non-retail contexts. Neither standard guarantees performance, eliminates risk, or converts a private placement into a suitable investment for any particular person.
Disclosure Quality
Limited disclosure typical of private placements—offering documents provide company business description, valuation, recent financing history, and risk factors but lack detailed financial statements, quarterly reporting, or ongoing disclosure obligations unlike public companies. Investors receive basic deal terms, fee structure, SPV structure details, and tax implications (K-1 forms). No comprehensive financial data, operational metrics, customer statistics, or management changes disclosed beyond what companies voluntarily provide. Information asymmetry heavily favors company insiders and earlier investors with board seats and information rights. Platform provides proprietary research and market insights but relies on same limited public information available to all investors. Disclosure improves slightly for larger direct share acquisitions where investors may negotiate limited information rights, though most secondary buyers receive minimal ongoing updates until exit event.
Custody Model
SPV LLC or fund entity holds underlying company shares on behalf of investors; platform or affiliate acts as SPV manager; investors hold membership interests in SPV not direct shares; EquityZen Securities LLC (registered broker-dealer) facilitates transactions but is not custodian of shares
Regulatory Backing
EquityZen Securities LLC is a SIPC member. SIPC may protect qualifying customer cash and securities held by the broker-dealer if the firm fails, subject to statutory limits, and coverage depends on what customer property the broker-dealer actually holds. It does not protect against declines in value, issuer failure, or losses in the underlying private investment — and SPV membership interests held through a fund vehicle are not equivalent to securities held in a customer brokerage account.
FINRA oversight and SEC regulation provide anti-fraud protections; retail recommendations are governed by Regulation Best Interest, while FINRA Rule 2111 suitability continues to apply in relevant non-retail contexts. There is no FDIC insurance. The private-placement structure means materially less regulatory disclosure and fewer investor protections than public securities carry.
Tax Treatment
Reporting
Schedule K-1 (Form 1065) commonly issued for SPV and fund membership interests; direct share acquisitions may receive different treatment depending on structure
K-1 issuance depends on vehicle type. Standard single-company funds usually issue a K-1 only when a taxable event occurred during the year, such as an exit, liquidation, or Express Deal sale; when no taxable event occurs, investors may receive no tax form for that year. Diversified managed funds generally issue annual K-1s from inception through liquidation, typically in late March or early April. Dual-layer funds that invest through an upstream third-party vehicle can be materially delayed because EquityZen must wait for the upstream K-1 first, pushing investor delivery into August or September.
Income Character
Capital gains (short-term or long-term depending on holding period) upon exit; annual K-1 may report phantom income, ordinary income, or other items during hold period
Tax treatment of SPV membership interests follows partnership taxation rules where investors report their allocable share of entity income, gains, losses, and deductions via Schedule K-1 even if they receive no cash distributions. Timing depends on vehicle type: standard single-company funds often issue a K-1 only in years with a taxable event, diversified managed funds generally issue annual K-1s, and dual-layer funds can be delayed until late summer because EquityZen must wait for upstream reporting. Upon exit, investors generally recognize capital gains, with long-term treatment more common because holding periods are usually measured in years rather than months.
During the hold period, K-1s can still report phantom income or loss allocations that affect basis without creating cash proceeds. State filing obligations may also arise depending on fund structure and source income. Direct share acquisitions may avoid some SPV-specific K-1 complexity, but treatment still depends on the exact offering documents and ownership structure.
Limitation
K-1 tax reporting creates complexity that usually warrants tax professional assistance. Investors should not assume all EquityZen vehicles issue forms on the same calendar: standard single-company funds may produce no K-1 in non-taxable years, diversified funds often arrive close to April 15, and dual-layer structures can arrive in August or September, making extensions effectively standard for some deals. Phantom income, passive-loss limitations, and potential multi-state filing obligations can create tax friction before cash liquidity exists. QSBS, AMT, and direct-share tax treatment are offering-specific and should be confirmed from the actual deal documents and a qualified tax adviser.
Account Suitability
Taxable
Suitable but complex—K-1 reporting requires tax professional assistance; capital gains treatment favorable if long hold periods (2-5+ years typical); phantom income during hold period may trigger taxes before cash received; multi-state filing requirements possible; QSBS potential if eligible.
Roth IRA
Usually impractical—most IRA custodians prohibit private placements due to operational complexity, K-1 reporting incompatibility, and UBTI concerns from certain partnership structures. Self-directed IRA custodians may accommodate them, but with substantial fees, administrative burden, and potential tax complications. Note that Roth IRAs do not impose required minimum distributions during the original owner's lifetime — the RMD constraint that applies to Traditional IRAs is not a factor here — but private-placement administration, annual valuation requirements, custodian availability and potential UBTI remain real practical obstacles. Confirm with a specialized custodian and tax adviser; not suitable for typical IRA accounts.
Traditional IRA
Usually impractical—same custodian restrictions and UBTI concerns as Roth IRA; K-1 reporting incompatible with IRA tax-deferral administration; illiquidity creates RMD distribution challenges. Specialized self-directed IRA custodians may allow but with significant fees, complexity, and potential UBTI tax liabilities. Not recommended for typical IRA accounts; verify with custodian and tax adviser if considering.
HSA
Impractical for nearly all investors. Standard HSA custodians are unlikely to support private placements, K-1 reporting, or annual valuation of illiquid assets. HSA funds may generally be invested in the same categories permitted for IRAs — the statutory prohibitions cover life insurance and collectibles rather than private or illiquid investments as a class — so whether a specific private placement is available depends on the custodian and the compliance structure. A specialized self-directed HSA may permit qualifying private investments, but custodian availability, prohibited-transaction rules, valuation requirements and administrative cost make this impractical for most investors, and an HSA's purpose is medical expense funding rather than illiquid private equity.
Before You Invest
Get EquityZen investor insights before you invest
K-1 timing, distribution updates, yield insights, and risk signals for EquityZen and similar platforms.
- Weekly platform research focused on tax timing and liquidity reality.
- Signals on distributions, risks, and structural tradeoffs before capital is locked up.
- Coverage of adjacent platforms so you can compare better options faster.
Get weekly platform signals
Track fee changes, liquidity updates, risk flags, and adjacent platforms before you invest.
Independent intelligence from AltStreet. No hype. No sponsor spin.
AltStreet Data Layer
What the data actually shows
AltStreet enumerated EquityZen's complete funded-SPV population from its broader Form D filing universe on SEC EDGAR (2,211 filings across 1,928 CIKs at the July 2026 enumeration, maintained since): 1,933 funded SPVs across six fund families, $1.565B raised across 49,673 subscription positions, 2015-2026. This is a census, not a sample — it supersedes AltStreet's prior 150-SPV figure, which covered roughly 8% of the population. Investor figures throughout are subscription counts, not unique investors: a person who invests in twelve SPVs is counted twelve times, and Form D does not permit de-duplication. Key findings from the structured data layer:
The retail product is going downmarket while the institutional one goes up
Growth Technology Fund I — 1,830 SPVs, $1.284B, EquityZen's core retail engine — has seen its median subscription fall from $28,143 (2015) to $22,170 (2017) to $23,345 (2021) to $15,651 (2025), a 44% decline from the 2015 level. Over the same period EquityZen launched Growth Technology Fund II (28 SPVs, $116.2M), whose median subscription rose from $75,107 (2024) to $133,987 (2025). Fund II's average check of $123,858 is roughly four times Fund I's $29,088.
What this means
EquityZen is not repositioning upmarket. It is bifurcating. Retail ticket sizes are moving lower while institutional ticket sizes are moving higher — this concerns subscription size, not business volume, which fell to a 2023 trough and has grown in each year since. A separate institutional product now operates alongside the retail channel at an entirely different scale. Which fund family a deal sits under determines what an investor is actually buying, and the two halves are moving in opposite directions. Investors should confirm the fund family before assuming the platform's headline economics apply to their deal.
One in five allocated Fund I series numbers has no corresponding Form D
EquityZen assigns Fund I series numbers sequentially, and the sequence is chronological — series blocks step forward cleanly through time. Of the 2,199 series numbers allocated through the matured range, 1,748 produced a Form D and 451 — 20.5% — never did. The rate is not constant.
It sits near 2% across the 2018-2021 series blocks, rises to 68% for series staged between June 2022 and March 2023, and falls back to roughly 9% for series staged in 2024-2026. A further 18 series filed a Form D disclosing no sales amount.
What this means
AltStreet observes that a series number was allocated and that no Form D followed. It does not observe why, and does not characterize these as failures — series staged in 2023 were still closing two years later, so some fraction of any recent gap is patience rather than collapse. What the record does show is that EquityZen's staging-to-close ratio broke down through the 2022 private-market drawdown and has since recovered. This is a primary-source measurement of when secondary deal formation froze, and the platform does not disclose it.
One $66M SPV accounts for half of Fund I capital in 2026 H1
EquityZen Growth Technology Fund LLC - Series 2300 raised $65,999,375 across 402 subscription positions — an average subscription of $164,178, against a stated minimum investment of $50,201. It filed a single Form D on April 8, 2026 at full size, with no amendments: the raise did not accumulate over months, it arrived complete. It is the largest SPV in EquityZen's history by a factor of four; the next largest is Growth Opportunity Fund VII Series 2 at $16.4M (2021).
Series 2300 alone accounts for 51.5% of the $128.2M Fund I raised across 89 SPVs in the first half of 2026. Excluding it, the remaining 88 SPVs averaged $707K — above 2024 ($401K) and 2025 ($529K), but below the 2021 peak average of $1.12M.
What this means
Fund I is nominally the retail vehicle, with a 2026 median subscription of $19,130 and an all-time median of $21,284. Series 2300 ran through it at an average subscription eight times that, and at a minimum ticket above the platform's standard single-company floor. A 402-investor book assembled in one filing is a syndication, not an institutional block — but it is a syndication four times larger than anything EquityZen had previously done, arriving in the first year of Morgan Stanley ownership. Aggregate statistics on EquityZen's 2026 activity are dominated by this single deal, and any figure quoted as a platform average for the year — including AltStreet's own — should be read with that concentration disclosed.
2023 was the trough, and every year since has been larger
Fund I capital raised by vintage: $383.0M (2021), $157.8M (2022), $64.3M (2023), $62.2M (2024), $101.5M (2025), $128.2M (2026 H1). Subscription positions follow the same shape: 12,687, 4,865, 2,706, 3,034, 5,065, 2,806-and-counting. Because the recorded figure is amount sold at the latest filing and can only rise with subsequent amendments, every year here is a floor.
What this means
The claim that EquityZen's retail business declined after 2022 and never recovered is not supported by the filing record: volume collapsed 83% from the 2021 peak to the 2023 trough, then grew in each of the three following years. Two caveats bound that conclusion. 2026 is a half-year observation, and its $128.2M is heavily distorted by a single $66.0M SPV — excluding it, the remaining 88 SPVs raised $62.2M. And AltStreet cannot attribute any of this to the Morgan Stanley acquisition; the filing record shows what happened, not why.
The one fund EquityZen shows you returned 2.07x — and cannot be annualized
EquityZen Growth Opportunity Fund II LLC (2016 vintage, CIK 1680698) raised $1,058,750 from 39 subscription positions and is the only EquityZen vehicle for which the platform publishes per-company realized returns. It is fully realized: 15 investments, 15 exited, 0 active. Fourteen are charted.
Median return 2.07x, mean 2.08x, range 0.15x (Tintri) to 4.20x (Palantir). Two of the fourteen returned less than capital — a 14.3% loss rate. It is also the only vehicle in which EquityZen names its portfolio companies.
What this means
The figures are multiples, not annualized returns, and cannot be converted into them: hold periods are disclosed nowhere on the page. A 2.03x on AppDynamics (acquired within months of the fund's 2016 close) and a 2.10x on Sprinklr (which did not list until 2021) are rendered as adjacent bars of near-identical height. EquityZen's own footnote further confirms the figures exclude carried interest, which multi-company funds do charge, and the chart is equal-weighted by company rather than by capital deployed — so it is not the fund's return. Three separate omissions, each moving the number in the same direction. This fund's equal-weighted company multiples cannot be reconciled against EquityZen's platform-wide 74% net aggregate figure at all: one is equal-weighted and apparently gross of carry, the other is described as net and of unknown weighting, the populations differ, and neither discloses hold periods. AltStreet does not infer from the gap that unpublished vehicles performed worse — the two numbers are simply not comparable, and that is itself the finding.
The same share, on the same day, at a 42% spread
On EquityZen's live Harness deal page, observed 13 July 2026, eleven simultaneous listings offered the identical security — Class B Common Stock — at prices from $19.00 to $27.00 per share, implying valuations from $4.1B to $5.8B. Every listing sat above EquityZen's own published Reference Price for the company. The listing marketed at the largest discount to the last primary round was still a premium to that Reference Price. Displayed ask volume exceeded displayed bid volume by roughly thirteen to one.
What this means
There is no single clearing price. The page did not flag the cheaper concurrent listings, display a best available price, or disclose any mechanism routing buyers toward the lowest-priced offer. Two investors purchasing the same security through the same platform on the same day can therefore pay materially different prices depending on which listing they select. The prominent discount figure is anchored to the last venture round — a stale, privately negotiated mark — rather than to EquityZen's own reference valuation, against which the same deals price at a premium. This is a single-company observation on a single day and AltStreet does not present it as a measured platform-wide average; it is, however, a direct consequence of a structure in which sellers set their own asks and multiple offerings run concurrently.
Express is a fast, expensive way in — and a restricted way out
On the Harness page, Express listings were both the quickest to settle (1-2 weeks, versus 6-12 weeks for Direct and Standard) and the most expensive, occupying the top of the price range. Their stated minimums were irregular, to-the-cent figures — $13,647.25, $40,172.00, $92,233.20 — because an Express listing is an entire existing SPV position being resold, not a subscription tranche. Selling into Express, by contrast, requires holding more than 2% of the original fund's units and finding a single buyer for the whole block.
What this means
The asymmetry is the point. Express is broadly available as an entry — anyone can buy a resold block, and small blocks do exist — but it is largely unavailable as an exit to the retail investors who entered at the platform's low minimums. Investors are paying a premium for speed on the way in, then discovering that the same mechanism will not carry them out. Underwrite the position as illiquid regardless of what the Express listings suggest about liquidity.
The exit record is double-locked, and cannot be assembled from either side
EquityZen publishes closed deals on its platform, but the closed-deal page carries no raise size, no terms, and no outcome — it shows company background, a Reference Price, and aggregate bid/ask volume, and nothing about the transaction that closed. The corresponding SEC Form D discloses the raise, the investor count and the exemption, but identifies the vehicle only as an anonymous series number and never names the company. Neither surface alone establishes an exit, and the two cannot be joined.
What this means
Outside Growth Opportunity Fund II, AltStreet holds no verified exits for EquityZen across the remaining 1,889 SPVs and this is not a coverage gap that further research can close. It is a structural property of how the two disclosure surfaces are shaped. The platform's 74% net aggregate return is therefore not only subject to realization bias; it is unauditable by any external party, and will remain so unless EquityZen voluntarily publishes a return distribution and hold periods, or resumes naming portfolio companies in its filings as it did before 2016.
EquityZen used to name the company in its filings, and stopped
EquityZen's pre-2016 vehicles were registered under company-specific names: EquityZen Palantir Fund LLC, EquityZen Lyft Fund LLC, EquityZen DocuSign Fund I LLC, EquityZen Cloudera Fund LLC, EquityZen MongoDB Fund LLC and others. Every Fund I vehicle since is registered as an anonymous serial — 'EquityZen Growth Technology Fund LLC - Series 2245' — and the portfolio company appears nowhere in the Form D. Hiive, a directly comparable platform, registers its vehicles as 'HII Anthropic-01' and 'HII Cerebras Series IV', naming the company in the SEC record.
What this means
Company-level concentration cannot be reconstructed for EquityZen from primary sources. No investor, and no analyst, can determine from public filings how much of the platform's $1.284B sits behind any single issuer. Any concentration or diversification figure EquityZen publishes is unauditable by construction. This is a disclosure choice rather than a regulatory requirement — EquityZen made the opposite choice for its first two years, and a direct competitor still does.
The Form D offering amount tells you nothing about the target raise
Across every EquityZen Growth Opportunity Fund XI amendment on file, the total offering amount and the total amount sold are amended to identical figures. Series 2 moved through $1,485,000, $2,152,000, $2,727,000 and $6,198,847 on both fields simultaneously between November 2025 and June 2026, ending at 143 subscription positions. EquityZen restates the offering size to match settled subscriptions rather than declaring a target and filling against it.
What this means
The offering amount field on an EquityZen Form D describes what has already been sold, not what the sponsor intended to raise. Screening tools and investors who read a rising offering amount as evidence of an expanding mandate are reading a bookkeeping artifact. A structural consequence: an EquityZen offering can never appear undersubscribed on EDGAR.
The 2022 drawdown is visible in the filings, and it was severe
Fund I subscription positions fell from 12,687 (2021) to 4,865 (2022) to 2,706 (2023). Capital raised fell from $383.0M to $157.8M to $64.3M — an 83% decline peak to trough. Median subscription held roughly flat through the collapse ($23,345 to $23,747 to $19,336), so the contraction came from fewer subscribers and fewer deals, not smaller checks. The staged-but-never-filed rate over the same window ran at 68%.
What this means
Investors who entered 2021-vintage EquityZen deals did so during the platform's most active year by a wide margin, at the top of a cycle that then fell 83%. Some of those positions have certainly exited by now and may be reflected in the platform's realized-return figure. Any that remain unresolved are four to five years into a holding period with no publicly verifiable mark, and would fall outside a realized-only aggregate by construction. The filing record discloses neither which is which, nor what the unresolved positions are currently worth.
Thematic Fund appears inactive
EquityZen Thematic Fund LLC comprises 15 SPVs and $25.3M across AI/ML, Fintech, Gaming, Future of Food, Future of Health, Enterprise SaaS and Most Requested themes, at a $24,468 average subscription. Its last Form D filing was May 2024, and no new series have been filed since. AltStreet observes the absence of filings, which indicates inactivity but does not establish that the product has been formally discontinued.
What this means
The themed basket product appears not to be a current option. Investors seeking thematic diversification are left with the Growth Opportunity Funds (17 SPVs, $68.7M, $53,320 average subscription) or with assembling their own basket from individual Fund I SPVs — at a median subscription that has been falling for a decade.
Data as of 2026-10-23 . AltStreet platform_exits database . Confidence level 4
Full datasetDecision Fit
Investor Fit
Who this works for, who it does not, and what level of patience and complexity tolerance the platform really demands.
Accredited investors seeking alternatives allocation with long time horizons
Pre-IPO investments provide exposure outside public markets with potential for substantial returns if companies achieve successful exits, although economic performance remains sensitive to public-technology valuations, interest rates and IPO conditions; reported prices may simply appear less volatile because they are not continuously marked. Suitable for sophisticated investors who can size the position so that a total loss would not compromise core financial needs, and whose time horizon aligns with multi-year hold periods. The platform provides access to late-stage companies otherwise unavailable to retail investors, at minimums far below traditional venture capital fund commitments — though availability of any specific company is supply-driven and inconsistent.
High-net-worth individuals and family offices building diversified private equity exposure
Investors with substantial capital can build a diversified portfolio across multiple single-company positions or multi-company funds, reducing single-name binary risk while maintaining upside potential. Diversification here requires materially more capital than the advertised minimum implies. Direct share acquisitions ($200K+ minimums) provide cap table presence and potential information rights.
Suitable for investors with independent due diligence capabilities, understanding of venture capital economics, and ability to underwrite companies with limited disclosure. Platform facilitates private equity allocation without requiring primary venture fund commitments or institutional relationships.
Investors seeking specific company exposure with strong conviction
Single-company funds enable targeted bets on specific late-stage companies where investor has independent conviction (e.g., SpaceX if bullish on commercial space, OpenAI if bullish on AI). Suitable for investors who have researched company's market position, competitive dynamics, and exit trajectory, and can tolerate concentrated exposure. Requires acceptance that single-company bet can result in 100% loss but also potential for multi-bagger returns if thesis correct.
Financial advisors managing HNW client portfolios
Platform provides advisors with mechanism to access private markets for qualified clients, but illiquidity creates portfolio management challenges. Suitable for advisors with clients seeking alternatives exposure as part of comprehensive financial plan, though limited information disclosure makes ongoing monitoring difficult. Must carefully assess client suitability (accreditation, risk tolerance, time horizon, liquidity needs) and ensure clients understand fee structures, illiquidity, and binary risk potential. Ongoing client education required as hold periods extend.
Income-focused investors requiring regular distributions
Pre-IPO investments generate zero income during hold period—no dividends, interest, or distributions until exit event (2-5+ years minimum). All returns back-loaded to exit timing creating poor fit for retirees or investors requiring cash flow. K-1 forms may report phantom income triggering taxes without cash to pay them. Not suitable for investors expecting regular income or distributions.
Risk-averse investors seeking principal protection or stable returns
Single-company funds create concentrated exposure with potential for 100% capital loss if company fails or is acquired at unfavorable terms. Binary outcomes (total loss or substantial gains) unsuitable for conservative investors requiring stability. Private market valuations opaque and potentially volatile.
Historical returns highly variable (100% loss to 450%+ gains) with no guarantee of positive outcomes. Not suitable for capital preservation strategies.
Investors requiring liquidity for emergencies or near-term goals
Investments illiquid with typical 2-5+ year hold periods and no guaranteed exit mechanism. Cannot access capital for emergencies, home purchase, education expenses, or other near-term needs. Secondary marketplace sales unreliable and dependent on buyer demand plus company approval.
Time horizon mismatch creates forced selling at unfavorable terms or inability to meet financial obligations. Only suitable for capital that can remain locked up 5-10+ years.
Passive investors seeking set-and-forget strategies
Pre-IPO investing requires active research to evaluate companies with limited disclosure, ongoing monitoring of portfolio companies and exit market conditions, K-1 tax filing complexity, and suitability assessments as financial circumstances change. Not suitable for passive index fund investors preferring simple buy-and-hold strategies. Requires engagement with complex legal documents, understanding of private market dynamics, and willingness to conduct due diligence with incomplete information.
Tradeoffs
Key Tradeoffs
The attraction of pre-IPO access is real, but every benefit comes bundled with a corresponding liquidity, transparency, or pricing cost.
Access vs liquidity
Platform provides rare retail investor access to late-stage unicorns (SpaceX, OpenAI, Stripe) typically reserved for venture capital funds and institutions, but investments are illiquid with 2-5+ year hold periods and no guaranteed exit mechanism before company IPO/acquisition.
Potential upside vs valuation risk
Pre-IPO entry provides exposure before public market access enabling substantial gains if companies successfully IPO at premium valuations, but late-stage entry at $10B-$200B+ valuations means substantial appreciation already captured by earlier investors—requires belief in multi-hundred-billion-dollar outcomes just for venture-style returns.
Diversification vs capital requirements
Multi-company funds offer diversification across several holdings at a lower entry point, reducing single-name risk, but investors sacrifice company selection control and transparency. Assembling a comparably diversified portfolio from individual single-company funds requires substantially more capital than any single advertised minimum implies — which is itself an accessibility barrier that the headline minimum obscures.
Lower minimums vs fee drag
Platform enables pre-IPO investing at minimums far below traditional venture capital fund commitments ($250K-$1M+), democratizing access. The buyer directly bears 2.5% (post-February 2026); the seller separately bears 2.5%, for roughly 5% of platform-level friction. Down from the prior 8-10% structure, but the buyer still starts behind and must clear that plus illiquidity before beating liquid alternatives.
Professional facilitation vs limited information
EquityZen handles complex legal documentation, company ROFR negotiations, and SPV administration that individual investors couldn't replicate enabling participation, but secondary market structure means investors receive minimal company information disclosure and lack ongoing reporting, board access, or information rights that primary venture investors possess.
Avoid
Who This Is Not For
This section should be read as a filter, not an afterthought. If you need income, simplicity, or near-term access to capital, the structure is working against you.
Income investors requiring regular cash distributions or dividends
Pre-IPO investments generate zero income during 2-5+ year hold period—no dividends, interest, or distributions until exit event. All returns back-loaded to IPO/acquisition timing. K-1 forms may report phantom income triggering taxes without cash to pay them. Unsuitable for retirees or investors requiring cash flow.
Risk-averse investors seeking principal protection or stable returns
Single-company funds create 100% loss potential if company fails; binary outcomes unsuitable for conservative strategies. Private valuations opaque and potentially volatile. Historical returns range from total losses to 450%+ gains with no guarantee of positive outcomes. Not suitable for capital preservation.
Investors requiring liquidity within 1-3 years for known expenses
Investments illiquid with typical 2-5+ year minimum hold periods and no guaranteed exit. Cannot access capital for home purchase, education expenses, emergencies, or other near-term needs. Secondary sales unreliable. Time horizon mismatch creates inability to meet financial obligations.
Non-accredited investors not meeting SEC income or net worth thresholds
Platform strictly limited to SEC-defined accredited investors ($200K+ annual income, $300K+ joint, or $1M+ net worth excluding primary residence). SEC Regulation D private placements prohibited for non-accredited investors. No exceptions or alternative access paths available.
Passive investors seeking simple buy-and-hold index strategies
Pre-IPO investing requires active company research with limited disclosure, ongoing monitoring, K-1 tax complexity, and engagement with legal documents. Not suitable for set-and-forget investors preferring passive index funds. Requires due diligence capability and willingness to conduct research with incomplete information.
Investors unable to tolerate 100% capital loss on positions
Binary outcome risk means some positions will result in total loss—companies fail, are acquired unfavorably, or remain private indefinitely. Venture capital model expects many losses with few winners driving returns. Not suitable for investors requiring every position to generate positive returns or lacking emotional tolerance for substantial losses.
Editorial View
AltStreet Perspective
The compressed version of the review: what matters, what marketing tends to obscure, and how we would frame the platform for a serious allocator.
Verdict
Legitimate secondary marketplace providing accredited investors with unprecedented access to late-stage pre-IPO companies, but illiquidity, fee drag, and binary risks require careful suitability assessment
Positioning
The platform feels like a marketplace. It behaves like a private equity fund. That gap is where most investors get surprised. EquityZen's interface is consumer-grade — clean, curated, filled with recognizable company names. The underlying structure is institutional-grade complexity: SPV membership interests, K-1 reporting that varies by vehicle type, post-IPO lockups that extend beyond the IPO itself, and Express Deal liquidity that most small-ticket investors will never qualify for. The Morgan Stanley acquisition (January 2026) improves the platform's institutional credibility, cuts fees to the lowest in the market (2.5% buyer and seller), and adds distribution reach — but does not change the fundamental investment structure. Suitable investors are sophisticated accredited investors who understand they are buying a long-duration private placement, not a flexible pre-IPO trading account. The platform is not suitable for income seekers, liquidity-dependent investors, or anyone who has confused name recognition with information access.
The Bottom Line
Legitimate pre-IPO secondary marketplace for accredited investors, but best treated as a long-duration, K-1-generating private placement — not a trading platform.
Action
Next Steps
If you still want to engage after reading the review, these are the practical next moves that reduce avoidable mistakes.
Verify accredited investor status—confirm you meet SEC requirements ($200K+ annual income, $300K+ joint, or $1M+ net worth excluding primary residence) before proceeding; verification process and documentation requirements vary by specific offering structure.
Review EquityZen Help Center documentation at help.equityzen.com covering investment process, fee structures, accreditation requirements, SPV mechanics, tax implications, and deal types to understand platform operations.
Create account and browse current offerings—deal cadence typically described as bi-weekly with specific timing varying by market conditions; review offering documents, company descriptions, and deal terms for available opportunities; note that many high-demand deals have waitlists.
Assess capital allocation before browsing deals.
Determine an allocation that does not compromise near-term liquidity or core financial needs; avoid concentrating a material portion of investable assets in any single private company; and recognize that meaningful diversification across positions may require substantially more capital than the advertised platform minimum suggests. AltStreet does not publish target allocation percentages — those depend on circumstances only you and your adviser can assess.
Conduct independent company research using external sources—media coverage, Crunchbase/PitchBook data, competitive analysis, industry trends, public market comparable valuations—to supplement limited offering document disclosure before investing.
Model return scenarios accounting for fee drag—calculate breakeven appreciation (the buyer directly bears 2.5% post-February 2026; entry pricing above the platform's reference valuation may matter more than the fee), expected returns at various exit valuations, time-adjusted IRRs for different hold periods (2, 5, 7, 10 years), and impact of fees on net outcomes.
Consult a tax adviser regarding vehicle-specific K-1 timing, extension planning, phantom income, passive-loss treatment, potential multi-state filing, and whether any direct-share structure changes the expected reporting burden.
Consider multi-company funds for initial exposure—they provide diversification across several names at a lower entry point than assembling individual positions, reducing single-name binary risk. Suitable for investors testing the pre-IPO asset class before committing to concentrated single-company positions.
Build position over time across vintage years—avoid concentrating investments in single market period; deploy capital across multiple years creating rolling exit opportunities and reducing exposure to specific IPO market conditions.
Establish realistic expectations about outcomes—understand that many positions will generate losses, some will produce modest returns, and few will generate substantial gains driving portfolio performance; accept 5-10 year illiquidity and uncertain exit timing before committing capital.
AltStreet Research Desk
About to invest in EquityZen, or in an offering we haven't covered?
Commission an independent diligence report: the same filing-based analysis behind this review, applied to the specific investment in front of you before you wire the money.
- Built from primary sources: SEC filings, court records, capital structure, and marketing-versus-filings comparison.
- From $750; full reports from $1,495. Fixed price confirmed up front, delivery in 3-5 business days.
- Independent by design: we work for investors and accept no compensation from the companies we cover.
EquityZen is in Deal Intelligence detection. Subscribers get the alert the day a new EquityZenoffering appears, with the sponsor's filed record attached, and the investment committee memo once an analyst approves it.
Deal Intelligence →Appendix
Sources, Disclosures, and Supporting Context
The lower section is structured like a report appendix: relationship context first, adjacent reading second, and evidence last.
Report Appendix
Disclosure
Relationship and compensation context
+
Report Appendix
Disclosure
Relationship and compensation context
Report Appendix
Comparison Guides
Head-to-head guides featuring EquityZen
+
Report Appendix
Comparison Guides
Head-to-head guides featuring EquityZen
Report Appendix
Related Resources
Adjacent platform comparisons, frameworks, and category links
+
Report Appendix
Related Resources
Adjacent platform comparisons, frameworks, and category links
Further Reading
Related Resources
Adjacent frameworks and reviews that help place the platform in a broader allocation or due-diligence context.
Explore Asset Class
Private Company Equity - Late-Stage Pre-IPOFund Landscape
Report Appendix
Related Coverage
AltStreet newsroom articles on EquityZen filings and disclosures
+
Report Appendix
Related Coverage
AltStreet newsroom articles on EquityZen filings and disclosures
- Nineteen EquityZen Series Report $10.5 Million Sold, Without Naming Underlying CompaniesOct 14, 2026
Nineteen series of EquityZen Growth Technology Fund LLC filed first Form D notices between September 22 and October 9, 2026, each reporting its full offering amount sold at filing, $10.5 million in total across 518 investor slots. None names the company whose shares it holds.
- EquityZen Registered 16 New Pre-IPO SPVs in August, Five of Them in the Final WeekAug 31, 2026
AltStreet's EDGAR monitoring counted 16 new EquityZen Growth Technology Fund series registered during August 2026, roughly four vehicles a week in the platform's first year under Morgan Stanley, with five filed between August 24 and 28 alone.
- EquityZen Quietly Launches a Sixth Fund Family as Its SEC-Filed Census Passes $1.5 BillionAug 24, 2026
A first Form D from EquityZen Growth Access Fund LLC ($10.39 million across 51 investors, filed under the qualified-purchaser exclusion) and the largest Growth Technology Fund II series ever filed arrived within three weeks of each other. Seven months after the Morgan Stanley acquisition, no Morgan Stanley entity has appeared on any EquityZen Form D.
- EquityZen Fund XI Series 2 Reaches $6.2M, 143 Investors After Minimum Falls to $5KJul 28, 2026
A June Form D/A shows EquityZen Growth Opportunity Fund XI Series 2 more than doubled reported capital to $6.2 million and nearly tripled its investor count from February. An earlier amendment filed one week after Morgan Stanley closed its EquityZen acquisition had reduced the vehicle's minimum accepted investment from $20,000 to $5,000.
- EquityZen Fund XI Series 1 Investor Count Rises to 51, Up 82% From FebruaryJul 27, 2026
A June 5 Form D/A for EquityZen Growth Opportunity Fund XI Series 1 reports 51 investors, up from 28 in February and 16 when the vehicle launched in late 2025. The filing follows Morgan Stanley's January acquisition of EquityZen but does not establish a connection between the ownership change and the increase.
Report Appendix
Tracked Offerings
233 EquityZen offerings with disclosed terms in the AltStreet database
+
Report Appendix
Tracked Offerings
233 EquityZen offerings with disclosed terms in the AltStreet database
- EquityZen Growth Technology Fund LLC - Series 2414
- EquityZen Growth Technology Fund LLC - Series 2419
- EquityZen Growth Technology Fund LLC - Series 2413
- EquityZen Growth Technology Fund LLC - Series 2422
- EquityZen Growth Technology Fund LLC - Series 2427
- EquityZen Growth Technology Fund LLC - Series 2418
- EquityZen Growth Technology Fund LLC - Series 2396
- EquityZen Growth Technology Fund LLC - Series 2400
- EquityZen Growth Technology Fund LLC - Series 2415
- EquityZen Growth Technology Fund LLC - Series 2405
- EquityZen Growth Technology Fund LLC - Series 2407
- EquityZen Growth Technology Fund LLC - Series 2365
Report Appendix
SEC Filers Behind EquityZen
The largest issuers linked to EquityZen on EDGAR, by total reported sold; each page carries the filing record and the related persons
+
Report Appendix
SEC Filers Behind EquityZen
The largest issuers linked to EquityZen on EDGAR, by total reported sold; each page carries the filing record and the related persons
- EquityZen Growth Technology Fund LLC - Series 23002026 · $66.0M · 402 investors
- EquityZen Growth Opportunity Fund VII LLC - Series 22021 · $16.4M · 213 investors
- EquityZen Growth Technology Fund II LLC - Series 352026 · $10.4M · 33 investors
- EquityZen Growth Access Fund LLC2026 · $10.4M · 51 investors
- EquityZen Growth Technology Fund LLC - Series 23372026 · $10.1M · 24 investors
- EquityZen Growth Technology Fund LLC - Series 11052021 · $8.8M · 88 investors
- EquityZen Growth Technology Fund LLC - Series 10782021 · $8.7M · 64 investors
- EquityZen Growth Technology Fund LLC - Series 22732026 · $8.3M · 72 investors
- EquityZen Growth Technology Fund II LLC - Series 132025 · $7.5M · 61 investors
- EquityZen Growth Technology Fund LLC - Series 23692026 · $7.3M · 26 investors
- EquityZen Growth Technology Fund LLC - Series 23642026 · $7.1M · 63 investors
- EquityZen Growth Technology Fund II LLC - Series 182025 · $6.9M · 72 investors
- EquityZen Growth Technology Fund LLC - Series 14912022 · $6.8M · 92 investors
- EquityZen Growth Technology Fund II LLC - Series 252025 · $6.8M · 56 investors
- EquityZen Growth Technology Fund II LLC - Series 292025 · $6.7M · 102 investors
- EquityZen Growth Technology Fund LLC - Series 23682026 · $6.5M · 13 investors
- EquityZen Growth Technology Fund II LLC - Series 202025 · $6.4M · 55 investors
- EquityZen Growth Opportunity Fund XI LLC - Series 22026 · $6.2M · 143 investors
- EquityZen Growth Technology Fund LLC - Series 11162021 · $5.9M · 87 investors
- EquityZen Growth Technology Fund LLC - Series 6062020 · $5.8M · 84 investors
Report Appendix
Verified Exit Data
Deal-level exit records and their sources
+
Report Appendix
Verified Exit Data
Deal-level exit records and their sources
Report Appendix
Evidence & Methodology
Sources, scope, and how the review was assembled
+
Report Appendix
Evidence & Methodology
Sources, scope, and how the review was assembled
ASReview Evidence
Methodology
Review synthesized from multiple source categories: (1) EquityZen platform materials (equityzen.com) including investor, shareholder, about, institutional, and legal pages; (2) EquityZen Help Center documentation covering investment process, fees, accreditation requirements, deal types, and FAQs; (3) the April 23, 2026 EquityZen dossier updates supplied for this review, which materially clarified tax timing, extension expectations, lockup mechanics, and Express Deal eligibility constraints; (4) comparator platform materials from Forge Global and Hiive, plus Forge's merger history with SharesPost for current-market positioning; (5) third-party platform reviews from FinanceBuzz, BullishBears, Fintorial, YieldTalk, TradingBrokers, and MoneyMade; and (6) SEC/FINRA regulatory records. Analysis focuses on investment structures, fee models, accreditation requirements, liquidity mechanics, tax treatment, investor suitability, and current competitive positioning.
Scope
Company history, platform scale and transaction volumes, investment structures, minimum investment requirements and enhanced access program, fee structure, accreditation requirements and verification process, investment process from signup through exit, SPV and fund mechanics, K-1 timing by vehicle type, extension risk, hold periods and post-IPO lockup mechanics, exit routes including Express Deal constraints, regulatory framework, information disclosure limitations, risk analysis, and investor suitability across different profiles.
Key Findings
- *CONFIRMED (Morgan Stanley press releases + Reuters): Morgan Stanley acquired EquityZen in January 2026 (announced October 29, 2025; closed January 27, 2026). First acquisition under CEO Ted Pick. Terms undisclosed; ~$100M integration costs expected over two years. EquityZen Securities LLC and EquityZen Advisors LLC are wholly-owned subsidiaries of EquityZen Inc., which is now owned by Morgan Stanley Wealth Management.
- *CONFIRMED (Morgan Stanley press release February 19, 2026): Transaction fees cut to 2.5% (buyer and seller) effective immediately, down from prior tiered structure (5%/4%/3% buyer, 5% seller). Industry-lowest $5,000 minimum maintained. Fee reduction also applies to Express Deals.
- *PLATFORM-CONFIRMED: Scale metrics refreshed in April 2026 materials: 850K+ total subscribers, 450+ companies served, and 53K+ company-approved transactions since 2013.
- *PLATFORM-CONFIRMED: Investment minimums: $10,000 for enhanced access members maintaining $50,000 balance; $20,000 limited slots for multi-company funds on first-come-first-serve basis; $50,000 standard minimum for single-company funds (per platform terms of service and Help Center).
- *PLATFORM-CONFIRMED: Fee structure updated February 19, 2026 following Morgan Stanley acquisition: 2.5% buyer fee on investments up to $1M, 2.0% above $1M; 2.5% seller fee at close; no carried interest or ongoing management fees on single-company SPVs. Prior structure (5%/4%/3% tiered) no longer applicable. For Direct Share Acquisitions: 2.5% up to $10M, 2.0% above $10M (per Morgan Stanley press release February 2026 and EquityZen Help Center).
- *PLATFORM-CONFIRMED: 74% net aggregate return across realized investments (per platform investor page). AltStreet characterizes this as realization bias rather than survivorship bias: the figure covers the realized portion of the portfolio and excludes the unresolved portion, but whether written-down or liquidated positions are counted as realized exits is not disclosed. Hold periods, capital weighting, vintage composition and the return distribution are all undisclosed, so the figure cannot be annualized, weighted, or independently verified.
- *PLATFORM-CONFIRMED: Investment process details as described in platform materials; company ROFR approval processes and transaction timelines vary by offering. Investors should not assume platform-level timing guidance overrides deal-specific documents.
- *PLATFORM-CONFIRMED: Accreditation requirements: $200K+ annual income ($300K+ joint) in prior two years with reasonable expectation of same, OR $1M+ net worth excluding primary residence; verification methods vary by offering structure (per Help Center accreditation page).
- *PLATFORM-CONFIRMED: Examples of companies featured on platform homepage include SpaceX, OpenAI, Anthropic, Stripe, Databricks, Anduril Industries, xAI, Perplexity, Groq, Figure AI, Lambda (per platform homepage as of January 2026); specific inventory varies based on shareholder supply and deal flow.
- *PLATFORM-CONFIRMED: Three investment structures: Single-company funds (standard and Express Deals), multi-company funds (Growth Opportunity and Thematic), and direct share acquisitions for $200K+ investors (per investor page).
- *THIRD-PARTY REPORTED: Historical returns range from 100% loss to 450%+ gains per FinanceBuzz and BullishBears analyses; distribution highly skewed with few winners driving aggregate returns.
- *THIRD-PARTY REPORTED: Typical hold periods 2-5 years though many extend longer as companies delay IPOs; 2018-2021 vintages remained illiquid through 2024 as IPO markets closed (per third-party analyses and market observations).
- *THIRD-PARTY REPORTED: SPV structures generally mean investors receive LLC membership interests and K-1 tax reporting rather than direct stock ownership, though actual issuance timing depends on vehicle type (per YieldTalk, TradingBrokers, and dossier-supported review synthesis).
- *RESEARCH-SUPPORTED: Secondary marketplace liquidity is conditional rather than dependable. Express Deals are real, but availability depends on ownership size, holding period, buyer demand, and company approval, making them a weak liquidity assumption for many smaller investors.
- *RESEARCH-SUPPORTED: K-1 timing is vehicle-specific: standard single-company funds usually issue only in taxable-event years, diversified managed funds generally issue annual K-1s, and dual-layer funds can be delayed into August or September because upstream reporting must arrive first.
- *RESEARCH-SUPPORTED: Post-IPO liquidity can still be delayed by the later of a standard lockup expiry or one year from the fund purchase date, so an IPO does not necessarily create immediate saleability.
- *ALTSTREET ASSESSMENT: The 74% net aggregate figure cannot be annualized from published data. EquityZen discloses no hold periods, so any annualization requires assuming one. It describes the figure as net without defining what net includes, so deducting the buyer fee again risks double-counting. It publishes no return distribution, no vintage composition and no capital weighting. Four inputs are missing, and only EquityZen can supply them.
- *COMPARATOR-SUPPORTED: Forge currently positions itself around deeper private-market data and larger direct transactions, Hiive emphasizes a live anonymous marketplace with institutional participation, and SharesPost now mainly matters as legacy context because Forge completed its SharesPost merger in November 2020.
- *THIRD-PARTY REPORTED: Platform focus on late-stage companies valued $500M+ with significant VC backing and perceived proximity to IPO/acquisition (per TradingBrokers and other reviews).
- *ALTSTREET IDENTIFIED (SEC EDGAR quarterly master index, 2014-2026): EquityZen's complete Form D filer population was 2,211 filings across 1,928 distinct CIKs at the July 13, 2026 enumeration. Maintained against new filings, the census stands at 1,933 funded SPVs totaling $1.565B across 49,673 subscription positions as of August 24, 2026. The first Form D filing dates to Q1 2014; the first filing disclosing sales is 2015. This is an enumerated census, not a sample.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): Growth Technology Fund I median subscription has declined from $28,143 (2015) to $15,651 (2025) — a 44% fall across 1,830 SPVs and $1.284B. Over the same period Growth Technology Fund II median subscription rose from $75,107 (2024) to $133,987 (2025). The retail and institutional channels are moving in opposite directions.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): EquityZen assigns Fund I series numbers sequentially. Of 2,199 series numbers allocated through the matured range, 1,748 produced a Form D and 451 (20.5%) did not. The rate is near 2% across the 2018-2021 blocks, 68% for series staged between June 2022 and March 2023, and roughly 9% for 2024-2026. A further 18 series filed a Form D disclosing no sales amount. AltStreet observes the absence of a filing; it does not observe cause and does not characterize these as failures.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): EquityZen Growth Technology Fund LLC - Series 2300 raised $65,999,375 across 402 subscription positions in 2026 — the largest SPV in EquityZen's history by a factor of four, and 51.5% of all Fund I capital raised in the first half of 2026. The next largest is Growth Opportunity Fund VII Series 2 at $16.4M (2021). Excluding Series 2300, the remaining 88 Fund I SPVs of 2026 H1 averaged $707K, below the 2021 peak average of $1.12M. Aggregate 2026 statistics for this platform are dominated by a single deal.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): Fund I capital raised by vintage — $383.0M (2021), $157.8M (2022), $64.3M (2023), $62.2M (2024), $101.5M (2025), $128.2M (2026 H1). Volume fell 83% from peak to the 2023 trough and has grown in each of the three years since. Because recorded figures are amount sold at the latest filing and can only rise with amendments, each is a floor.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): EquityZen registered its pre-2016 vehicles under company-specific names (EquityZen Palantir Fund LLC, EquityZen Lyft Fund LLC, EquityZen DocuSign Fund I LLC, and others). Every Fund I vehicle since is registered as an anonymous serial — 'EquityZen Growth Technology Fund LLC - Series 2245' — with the portfolio company named nowhere in the filing. Hiive, a directly comparable platform, names the company in the filer name ('HII Anthropic-01'). Platform-level company concentration is therefore unverifiable from primary sources for EquityZen and verifiable for Hiive.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): Across every EquityZen Growth Opportunity Fund XI amendment on file, total offering amount and total amount sold are amended to identical figures — Series 2 moved through $1,485,000, $2,152,000, $2,727,000 and $6,198,847 on both fields simultaneously between November 2025 and June 2026. EquityZen restates the offering size to match settled subscriptions rather than declaring a target and filling against it, which means an EquityZen offering can never appear undersubscribed on EDGAR.
- *ALTSTREET IDENTIFIED (SEC EDGAR Form D): Post-acquisition filings continue under EquityZen entity names. No Morgan Stanley filer appears on any Form D through August 2026, including the new Growth Access Fund LLC filer.
- *ALTSTREET IDENTIFIED (EquityZen platform materials, accessed 2026-07-13): EquityZen Growth Opportunity Fund II LLC (2016 vintage, CIK 1680698, $1,058,750 raised from 39 subscription positions) is fully realized — 15 investments, 15 exited. EquityZen publishes per-company returns for 14 of them: median 2.07x, mean 2.08x, range 0.15x to 4.20x, with 2 of 14 returning less than capital (14.3% loss rate). These are multiples, not IRRs. Hold periods are not disclosed, returns are gross of carried interest per the platform's own footnote, and the figures are equal-weighted by company rather than capital-weighted. This is the only EquityZen vehicle with published realized returns and the only one in which portfolio companies are named.
AltStreet Verified Data
Structured exit database - independently sourced
AltStreet enumerated EquityZen's complete Form D filer population from SEC EDGAR's quarterly master index (2014-2026): 2,211 filings across 1,928 distinct CIKs at the July 13, 2026 enumeration, with the census maintained against new filings since. As of August 24, 2026 it stands at 1,933 funded SPVs totaling $1.565B and 49,673 subscription positions across funded vintages 2015-2026 (the 2014 filings disclosed no sales and were correctly excluded). Fund family breakdown: Growth Technology Fund LLC (1,855 SPVs, $1.344B, 46,190 positions, $29,088 average and $21,350 median subscription — the retail engine); Growth Technology Fund II LLC (28 SPVs, $116.2M, 938 positions, $123,858 average and $119,993 median subscription — institutional); Growth Access Fund LLC (1 filing, $10.39M across 51 positions, July 2026 — a new fund family; its Form D claims Rule 506(b) with an Investment Company Act Section 3(c)(7) exclusion, a qualified-purchaser pooled-fund indicator, unlike the single-company series); Growth Opportunity Funds II-XI (17 multi-company baskets, $68.7M, $53,320 average); Thematic Fund LLC (15 themed baskets, $25.3M, last filing May 2024); pre-2016 per-company legacy vehicles (DocuSign, Palantir, Cloudera, Nutanix, MongoDB, GitHub, Box, Lyft and others — a naming convention EquityZen abandoned). Excluded from all aggregates: EquityZen Inc. (the operating company's own venture raise, CIK 1652370), EquityZen Late Stage Fund LLC, and EQUITYZEN ZD FUND LLC — none are single-company SPVs. This is a census, not a sample. It supersedes the prior 150-SPV figure, which represented roughly 8% of the population and 16% of the capital. No verified IRR data — portfolio company names are not disclosed in Fund I Form D filings, which prevents cross-referencing against public exit events. Investor figures are subscription counts, not unique investors; Form D does not permit de-duplication across SPVs. VERIFIED RETURNS: one vehicle only. EquityZen Growth Opportunity Fund II LLC (2016, CIK 1680698) is fully realized and the platform publishes per-company returns for 14 of its 15 exits — median 2.07x, mean 2.08x, 14.3% loss rate. These are multiples; no hold periods are disclosed, so no IRR is derivable, and they are gross of carried interest and equal-weighted by company. Across the other 1,932 SPVs, AltStreet holds no verified exit data and cannot obtain any: Fund I Form D filings do not name the portfolio company, and the platform's closed-deal pages disclose neither raise nor outcome.
Data as of 2026-07-13. Exit status breakdown: 0 exited . 0 open . 0 unreported.
Primary Source Pages
FAQ
Frequently Asked Questions
High-intent search questions answered directly, without making users hunt through the full review.
Is EquityZen legit?
Yes. EquityZen runs its marketplace through EquityZen Securities LLC, an SEC-registered broker-dealer, FINRA member (CRD 281820) and SIPC member, and it has been a wholly owned subsidiary of Morgan Stanley Wealth Management since the acquisition closed on January 27, 2026. Its activity is on the public record: AltStreet's census of its Form D filings counts 1,967 funded SPVs that raised $1.592 billion across 50,548 subscription positions as of October 23, 2026. Legitimate is not the same as low risk. In most deals you buy a membership interest in an SPV rather than shares, the money is usually tied up for years, the platform's own documentation says a company's right of first refusal can end a transaction after you commit, and most SPVs send a K-1.
What do EquityZen reviews say?
Many EquityZen reviews repeat two platform figures: a $5,000 minimum and a 74% net aggregate return on realized investments. AltStreet's review checks them against the filing record. Minimums vary by deal: AltStreet saw Standard listings at $10,000 on July 13, 2026 and Direct listings from roughly $152,000 to $300,000. The 74% covers realized investments only, and EquityZen publishes no hold periods, so it cannot be turned into an annual return. Since about 2016 EquityZen's Form Ds no longer name the company an SPV holds, and 20.5% of the Fund I series numbers in the matured range never produced a Form D. On cost, the buyer fee has been 2.5% since February 19, 2026.
Is EquityZen worth it?
It depends on what you need from the money. The cost is a 2.5% buyer fee up to $1 million and 2.0% above, so a $50,000 investment requires a $51,250 wire, with no carried interest or ongoing management fee on single-company SPVs. What you get is usually an SPV interest held for several years: an IPO does not end the wait, because sale can be delayed until the later of the lockup expiry or one year from the fund's purchase date, and most SPVs send a K-1. It can make sense for an accredited investor who wants exposure to a specific late-stage company, can leave the money untouched for years and can accept losing all of it on a single position. It does not suit anyone who needs liquidity or income.
Can I buy EquityZen stock?
No. EquityZen has been a wholly owned subsidiary of Morgan Stanley Wealth Management since January 2026, so there are no EquityZen shares to buy. Searches for EquityZen stock usually mean the private-company stock sold on the platform. In most Standard and Express offerings you buy a membership interest in an SPV that holds the company's shares, not the shares themselves; Direct acquisitions, at much higher minimums, are the exception.
What are EquityZen funds?
EquityZen files its SPVs under a few fund families, each series a separate LLC. EquityZen Growth Technology Fund LLC (Fund I) holds most single-company series: 1,883 SPVs and $1.369 billion as of October 23, 2026. Growth Technology Fund II LLC carries larger tickets: 28 SPVs and $116.2 million as of September 16, 2026. The Growth Opportunity Funds (17 vehicles, $68.7 million) are curated multi-company portfolios, the Thematic Fund (15 SPVs, $25.3 million) has not filed since May 2024, and Growth Access Fund LLC filed for the first time on July 22, 2026. Buying into a fund series gets you an interest in that LLC and a K-1, not shares of the company.
EquityZen vs Equitybee: what is the difference?
They sell different things. EquityZen is a secondary marketplace: an existing shareholder sells, and you usually buy an SPV interest that holds the shares, paying a 2.5% buyer fee. Equitybee funds an employee's stock-option exercise through a Series LLC; you hold a contingent claim on that employee's proceeds, never the shares, and pay a 5% front-end brokerage fee plus 5% carried interest on the interest and equity-share portions of proceeds. On EDGAR, EquityZen's census stands at 1,967 funded SPVs and $1.592 billion as of October 23, 2026, and Equitybee's at 1,093 series reporting $231.1 million sold to 3,634 investor slots as of October 22, 2026. AltStreet's Equitybee vs EquityZen guide covers fees, returns, taxes and exits side by side.
Where can I find news on EquityZen?
This review keeps a dated update history at the bottom of the page. Recent entries: Morgan Stanley closed its acquisition of EquityZen on January 27, 2026; the fee cut to 2.5% on each side took effect on February 19, 2026; and the October 23, 2026 census refresh added 24 new Growth Technology Fund series filed between September 22 and October 22, bringing the count to 1,967 SPVs and $1.592 billion. For company announcements, EquityZen's own site is the primary source.
What is EquityZen and how does it work?
EquityZen is a secondary marketplace connecting accredited investors with pre-IPO shares in late-stage private companies. Existing shareholders sell equity, and EquityZen typically wraps the purchase in an SPV LLC so investors buy membership interests rather than direct stock. Investors usually realize value only when the company is acquired, goes public, or in limited cases when an eligible Express Deal resale occurs.
What is the EquityZen minimum investment?
EquityZen advertises entry minimums as low as $5,000, but minimums vary materially by deal and by deal type. AltStreet observed Standard listings at a $10,000 minimum on 13 July 2026, while older platform materials cite $50,000 as the standard single-company minimum. Direct listings observed the same day ranged from roughly $152,000 to $300,000, against platform materials citing $200,000+. Express listings carry irregular, to-the-cent minimums because each represents an entire existing SPV position being resold. Treat any single published minimum as indicative. Enhanced access ($10,000 minimum, waitlist priority, early deal access) requires maintaining a $50,000 platform balance. Multi-company funds have $20,000 limited slots on a first-come basis.
What fees does EquityZen charge?
Post-February 2026 (Morgan Stanley acquisition): Investors pay 2.5% up to $1M, 2.0% above $1M. Example: $50,000 investment requires $51,250 wire. Sellers separately pay 2.5% at close. Platform does not charge carried interest or ongoing management fees on single-company SPVs. Platform-level friction is roughly 5% per completed transaction, but the buyer directly bears 2.5% of it — the seller-side fee is not an additional charge against the buyer, though it may be reflected in asking prices. Reduced from the prior 8-10% structure.
How long do I have to hold EquityZen investments?
Typical underwriting assumption is a multi-year hold, often 2-5+ years, but actual liquidity can take longer. If a company goes public, sale timing may still be constrained until the later of the post-IPO lockup expiry or one year from the fund purchase date. Express Deal resale can happen sooner in some cases, but it is not broadly available and should not be treated as guaranteed liquidity.
Who can invest on EquityZen?
SEC-defined accredited investors only: $200K+ annual income ($300K+ joint with spouse) in each of prior two years with reasonable expectation of same, OR $1M+ net worth excluding primary residence. Entity investors require $5M+ assets or qualifying status. Verification method varies by offering structure: 506(b) offerings generally rely on investor questionnaires and binding representations, while 506(c) offerings may require additional documentation to satisfy the SEC's reasonable-verification standard. Non-accredited investors cannot access the platform.
What are EquityZen's historical returns?
Platform reports 74% net aggregate return across realized investments. This carries realization bias — it covers the realized portion of the portfolio and excludes the unresolved portion — and it cannot be annualized, because EquityZen publishes no hold periods. Whether written-down positions are counted as realized exits is not disclosed, so you cannot assume failures are excluded. Capital weighting and the return distribution are also undisclosed. Third-party sources cite individual outcomes ranging from total loss to 450%+ gains with a highly skewed distribution. Past performance is not predictive of future returns.
Can you buy SpaceX stock on EquityZen?
Sometimes, yes—but not reliably. EquityZen may periodically feature companies like SpaceX, OpenAI, Stripe, or Anthropic when existing shareholders want liquidity and the company allows the transfer structure. In practice, the deals many users care about are inconsistent, supply-driven, often oversubscribed, and not something you should assume will be available exactly when you want them.
How often are companies like OpenAI actually available on EquityZen?
Availability is opportunistic rather than dependable. A marquee company can appear because a seller is active, then disappear because the allocation fills, the company blocks or limits transfers, or the economics stop making sense. If you are joining primarily to buy one specific name, expect frustration: EquityZen is better understood as access to occasional late-stage secondary opportunities, not guaranteed access to whatever private company is currently trending.
What do EquityZen's returns look like in annualized terms?
No reliable annualized return can be calculated from what EquityZen publishes. The platform does not disclose the holding periods behind its 74% net aggregate figure, and a 74% gain over three years is a very different investment from the same gain over seven or ten. The figure is also described as net without defining what net includes, so subtracting the buyer fee from it again risks double-counting. And because it covers realized investments only — with no distribution, no vintage composition and no capital weighting disclosed — it cannot be independently verified. A large total-return number tells you very little without the clock, the weighting and the denominator.
What companies can I invest in through EquityZen?
EquityZen reports serving more than 450 companies historically, but the number currently available to investors is materially smaller and changes with shareholder supply. Companies that have appeared on the platform include SpaceX, OpenAI, Anthropic, Stripe, Databricks, Anduril Industries, xAI, Perplexity, Groq, Figure AI and Shield AI. Focus is on tech companies (AI, fintech, SaaS, defense tech, biotech) with significant VC backing. A company appearing in the catalog does not mean it is currently investable — availability depends on shareholders willing to sell and on company approval.
How does EquityZen compare with Forge Global, Hiive, and SharesPost?
EquityZen is generally the more retail-packaged option, with lower advertised minimums and more SPV-based access. Forge Global is more market-infrastructure-heavy, with stronger price discovery and larger direct transaction orientation. Hiive emphasizes a live marketplace, anonymity, and institutional buyer/seller interaction. SharesPost is mostly historical context now because Forge completed its merger with SharesPost in November 2020, so modern comparisons usually mean EquityZen vs Forge vs Hiive rather than EquityZen vs a standalone SharesPost platform.
How do I exit my EquityZen investments?
The primary exit path is a company liquidity event such as an IPO, merger, or acquisition. If the company IPOs, your shares may still be subject to a standard 180-day lockup and restricted-security timing rules that can extend actual saleability until the later of lockup expiry or one year from purchase. A secondary exit may be possible through an eligible Express Deal, but those resales depend on company approval, a qualified seller position, and a single buyer for the full block.
What are the main risks of investing through EquityZen?
Major risks: Illiquidity (2-5+ years minimum, no guaranteed exit); binary outcomes (100% loss if company fails); valuation risk (late-stage entry at $10B+ valuations limits upside); information asymmetry (minimal disclosure vs public companies); fee drag (buyer directly bears 2.5%; ~5% platform-level friction per transaction post-February 2026, down from 8-10%); company ROFR uncertainty (deals can fail after commitment); sector concentration (tech-heavy). Suitable only for sophisticated investors with long horizons and loss tolerance.
How many deals has EquityZen actually done?
AltStreet enumerated EquityZen's complete SEC Form D filer population from EDGAR's quarterly master index and keeps it current against new filings: 1,967 funded SPVs raising $1.592B across 50,548 subscription positions, funded 2015 to 2026 (census as of October 23, 2026). The bulk sits in Growth Technology Fund I (1,883 SPVs, $1.369B as of October 23), with Growth Technology Fund II (28 SPVs, $116.2M as of September 16), the Growth Access Fund (first filing $10.39M, July 2026), Growth Opportunity Funds (17), Thematic Fund (15) and a handful of pre-2016 per-company vehicles making up the rest. This is a census of the filing record rather than a platform-reported figure. Note that Form D reports subscription positions, not unique investors: the same person appearing in twelve SPVs is counted twelve times.
Can I find out which company an EquityZen SPV holds?
Not from SEC filings. EquityZen registers its Fund I vehicles under anonymous serial names — 'EquityZen Growth Technology Fund LLC - Series 2245' — with the portfolio company disclosed nowhere in the Form D. You learn the company from the platform's own offering materials once you are inside the deal, but no external party can audit platform-level company concentration. Notably, EquityZen did name companies in its filings before roughly 2016 (EquityZen Palantir Fund LLC, EquityZen Lyft Fund LLC), and competitor Hiive still does ('HII Anthropic-01'). The opacity is a choice, not a rule.
Do EquityZen deals ever fail to close?
The filing record suggests so, though the platform does not disclose a figure. EquityZen numbers its Fund I series sequentially, and AltStreet found that 20.5% of the series numbers allocated through the matured range never produced a Form D at all — near 2% during 2018-2021, spiking to 68% for series staged between June 2022 and March 2023, and back to roughly 9% by 2024-2026. AltStreet can observe that a series was numbered and no filing followed; it cannot observe why, and some fraction of any recent gap may be deals still working rather than deals that died. Separately, the platform's own documentation confirms that company ROFR can terminate a transaction after an investor has committed capital.
How are EquityZen investments taxed?
Most EquityZen SPV investments are taxed as partnership interests, so investors may receive Schedule K-1 reporting for income, gains, losses, and deductions even without cash distributions. Timing depends on structure: standard single-company funds often issue K-1s only in taxable-event years, diversified funds generally issue annual K-1s, and dual-layer structures can be delayed into August or September, making extensions common. Tax handling can also involve phantom income, passive-loss limits, and possible multi-state filing, so this is materially more complex than holding public stocks in a normal brokerage account.
What is EquityZen Growth Technology Fund LLC?
It is the Delaware series LLC under which EquityZen registers most of its single-company SPVs with the SEC. Each numbered series (Series 2300, for example) holds shares of one private company and files its own Form D, and investors receive an interest in that series plus a K-1 rather than shares of the company. In AltStreet's July 2026 census the fund family accounted for 1,830 of the platform's funded SPVs, $1.284 billion raised and 45,229 subscription positions, with a $30,955 average and $21,284 median subscription. Since 2016 the Form Ds no longer name the underlying company; AltStreet's platform data page shows how the series map to companies where the filings allow it. A second family, Growth Technology Fund II LLC, carries the larger-ticket vehicles ($118,298 median subscription), and Growth Access Fund LLC first filed in July 2026.
Who are EquityZen's competitors and alternatives?
Forge Global (Schwab-owned, $5,000 fund minimum, $100,000 direct minimum), Hiive (now Clarity, commissions of up to 4.85% for buyers and 5.75% for sellers, $25,000 direct minimum) and UpMarket are the closest alternatives for accredited investors buying pre-IPO shares. EquityBee is often listed as a competitor but does something different: it funds employees' option exercises in exchange for a share of the upside. Nasdaq Private Market and Augment serve mostly institutional and tender-offer flow. AltStreet's EquityZen vs Forge vs Hiive, EquityBee vs EquityZen and EquityZen vs UpMarket guides compare fees, minimums, ROFR exposure and tax reporting side by side.
Update History
What's changed in this EquityZen review
New data, new findings, corrections, and confirmations as they emerge. Most recent updates appear first.
- New data
CENSUS COUNTS (platform_exits, 2026-10-23): 1,967 funded SPVs, $1,592,287,119 raised, 50,548 subscription positions (from 1,943 / $1,577,831,351 / 49,950 on 2026-09-16). Fund I (EquityZen Growth Technology Fund LLC, series-numbered rows): 1,883 SPVs, $1,368,626,891, 46,979 positions, $29,133 average position. View section
- Confirmed
NEW SERIES (Form D, 2026-09-22 to 2026-10-22): Series 2367, 2383, 2385, 2384, 2375, 2397, 2390, 2379, 2380, 2378, 2386, 2401, 2366, 2395, 2406, 2382, 2387, 2392, 2404, 2398, 2412, 2407, 2405 and 2365 of EquityZen Growth Technology Fund LLC were each captured into the census by the sponsor watch with their filed totals; no backfill was needed. Series numbering continues to run ahead of filing order (2365 filed last, on October 22). View section
- Confirmed
DATA LAYER: 1,953 known CIKs; 45 entity profiles linked to the platform during this sweep (the nightly sync had created them with no platform), three known CIKs still awaiting a profile from the nightly enrichment. Analyst inputs and score unchanged. View section